[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 1791
1. Lachenmayer A, Lichtenauer UD, Cox T, Schott M, Malendowicz LK, Goretzki PE, Cupisti K, Scherbaum WA, Bornstein SR, Willenberg HS: Nestin as a marker in the classification of adrenocortical tumors. Horm Metab Res; 2009 May;41(5):397-401
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Expression of nestin mRNA could be detected in all microdissected tissues, independently of their grade of dedifferentiation.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19294612.001).
  • [ISSN] 1439-4286
  • [Journal-full-title] Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme
  • [ISO-abbreviation] Horm. Metab. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Intermediate Filament Proteins; 0 / NES protein, human; 0 / Nerve Tissue Proteins; 0 / Nestin
  •  go-up   go-down


2. Nicolin V, Ponti C, Baldini G, Gibellini D, Bortul R, Zweyer M, Martinelli B, Narducci P: In vitro exposure of human chondrocytes to pulsed electromagnetic fields. Eur J Histochem; 2007 Jul-Sep;51(3):203-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • No dedifferentiation towards the fibro- blastic phenotype occurred, indicating the success of the surgical implantation.

  • MedlinePlus Health Information. consumer health - Electromagnetic Fields.
  • MedlinePlus Health Information. consumer health - Knee Injuries and Disorders.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17921116.001).
  • [ISSN] 1121-760X
  • [Journal-full-title] European journal of histochemistry : EJH
  • [ISO-abbreviation] Eur J Histochem
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  •  go-up   go-down


3. Sturgeon C, Angelos P: Identification and treatment of aggressive thyroid cancers. Part 1: subtypes. Oncology (Williston Park); 2006 Mar;20(3):253-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Approximately one-third of patients with differentiated thyroid cancers will have tumor recurrences.
  • The loss of the ability to concentrate radioiodine and produce thyroglobulin is a sign of dedifferentiation, which occurs in about 30% of patients with persistent or recurrent thyroid cancer.
  • Dedifferentiation is associated with poorer responses to conventional therapy and difficulty monitoring tumor burden.
  • Part 2, which will appear in next month's issue, covers risk assessment and staging, findings that suggest the presence of aggressive tumors, recurrent/metastatic disease, and the value of treatment with chemotherapy and external-beam radiotherapy.

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16629257.001).
  • [ISSN] 0890-9091
  • [Journal-full-title] Oncology (Williston Park, N.Y.)
  • [ISO-abbreviation] Oncology (Williston Park, N.Y.)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0W860991D6 / Deoxycytidine; 80168379AG / Doxorubicin; B76N6SBZ8R / gemcitabine; P88XT4IS4D / Paclitaxel; Q20Q21Q62J / Cisplatin
  • [Number-of-references] 87
  •  go-up   go-down


Advertisement
4. Pham K, Gupta R: Understanding the mechanisms of entrapment neuropathies. Review article. Neurosurg Focus; 2009 Feb;26(2):E7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Because the accepted trigger for Schwann cell dedifferentiation is axonal injury, an alternate mechanism for Schwann response must exist in CNC injury.
  • These studies suggest that although the reciprocal relationship between neurons and glial cells is maintained, chronic nerve compression injury is a Schwann cell-mediated disease.

  • COS Scholar Universe. author profiles.
  • eScholarship, California Digital Library, University of California. Full text from University of California eScholarship .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19435447.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Myelin Proteins
  • [Number-of-references] 46
  •  go-up   go-down


5. Wang C, Han M, Zhao XM, Wen JK: Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid. J Biochem; 2008 Sep;144(3):313-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all-trans retinoic acid.
  • All-trans retinoic acid (ATRA) inhibits VSMC proliferation and induces VSMC differentiation.
  • Here, we show that treatment of VSMCs with ATRA resulted in significant inhibition of proliferation and migration of VSMCs, as well as up-regulation of KLF4 and the VSMC differentiation marker genes SM22alpha and SM alpha-actin (alpha-SMA).
  • At the same time, the KLF4 target gene p53 was up-regulated, while the VSMC dedifferentiation marker gene nonmuscle myosin heavy chain-B (SMemb) was down-regulated.
  • Thus, our data suggest that KLF4 is required for the expression of VSMC differentiation marker genes induced by ATRA and that this transcription factor is one of the key mediators of retinoid actions in VSMCs.
  • [MeSH-minor] Animals. Cell Differentiation. Cell Movement. Cell Proliferation. Humans. Male. Mice. Models, Biological. Rats. Rats, Sprague-Dawley. Time Factors

  • Hazardous Substances Data Bank. ALL-TRANS-RETINOIC ACID .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18511453.001).
  • [ISSN] 0021-924X
  • [Journal-full-title] Journal of biochemistry
  • [ISO-abbreviation] J. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / GKLF protein; 0 / Kruppel-Like Transcription Factors; 5688UTC01R / Tretinoin
  •  go-up   go-down


6. Khan S, Lloyd C, Szyszko T, Win Z, Rubello D, Al-Nahhas A: PET imaging in endocrine tumours. Minerva Endocrinol; 2008 Jun;33(2):41-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Being a marker of metabolically active lesions that show high grading and low differentiation, FDG is not ideal for this purpose since the majority of endocrine tumours are slow growing and highly differentiated.
  • It is however useful when dedifferentiation takes place and provides excellent prognostic information.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18414356.001).
  • [ISSN] 0391-1977
  • [Journal-full-title] Minerva endocrinologica
  • [ISO-abbreviation] Minerva Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Gallium Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Number-of-references] 71
  •  go-up   go-down


7. Chen GG, Vlantis AC, Chak EC, Liu HC, Tong MC, van Hasselt CA: The expression of Bcl-2 family proteins and spontaneous apoptosis in laryngeal carcinomas. Oncol Res; 2006;16(6):273-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bak was decreased in moderately differentiated tumors compared to well-differentiated tumors.
  • In contrast to Bak, the expression of Bcl-2 was increased in moderately differentiated tumors compared to well-differentiated tumors.
  • These results indicate that the reduction in Bak may be associated with an increase in tumor grade and dedifferentiation in laryngeal carcinomas.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cell Differentiation. Female. Humans. Immunohistochemistry. In Situ Nick-End Labeling. Male. Middle Aged. bcl-2 Homologous Antagonist-Killer Protein / analysis. bcl-2-Associated X Protein / analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17476972.001).
  • [ISSN] 0965-0407
  • [Journal-full-title] Oncology research
  • [ISO-abbreviation] Oncol. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BAK1 protein, human; 0 / BAX protein, human; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / bcl-2 Homologous Antagonist-Killer Protein; 0 / bcl-2-Associated X Protein
  •  go-up   go-down


8. Rhiemeier V, Breitenbach U, Richter KH, Gebhardt C, Vogt I, Hartenstein B, Fürstenberger G, Mauch C, Hess J, Angel P: A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin. Am J Pathol; 2006 Apr;168(4):1354-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Homeostasis of stratified epithelia, such as the epidermis of the skin, is a sophisticated process that represents a tightly controlled balance between proliferation and differentiation.
  • Taps mRNA and protein are restricted to stratified epithelia in mouse embryos and adult tissues, implicating a crucial role for this aspartic proteinase-like gene in differentiation and homeostasis of multilayered epithelia.
  • However, its expression is negatively associated with dedifferentiation and malignant progression in squamous cell carcinomas of the skin.
  • [MeSH-minor] Amino Acid Sequence. Animals. Cell Differentiation. Cell Line, Tumor. Dexamethasone / pharmacology. Epidermis / embryology. Epidermis / metabolism. Epithelium / embryology. Epithelium / metabolism. Female. Gene Expression Regulation, Developmental. Gene Expression Regulation, Neoplastic. Genes, fos. Humans. Mice. Mice, Inbred C57BL. Molecular Sequence Data. Tetradecanoylphorbol Acetate. Transcription Factor AP-1 / antagonists & inhibitors. Transcription Factor AP-1 / metabolism


9. Al-Maghraby HQ, Khalbuss WE, Rao UN, Cieply K, Dacic S, Monaco SE: Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH. Cytojournal; 2010;7:5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH.
  • Well-differentiated liposarcoma (WDLS) can undergo dedifferentiation to a nonlipogenic sarcoma of variable histologic grade.
  • We present a case of dedifferentiated liposarcoma diagnosed by fine-needle aspiration (FNA), using cytomorphology and ancillary studies (immunocytochemistry and fluorescent in-situ hybridization).
  • In addition, the findings were morphologically compatible with the previously resected retroperitoneal dedifferentiated liposarcoma with areas of osteosarcoma.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1992 Nov;16(11):1051-8 [1471725.001]
  • [Cites] Am J Surg Pathol. 2009 Nov;33(11):1594-600 [19574885.001]
  • [Cites] Cancer Res. 1995 Jan 1;55(1):24-7 [7805034.001]
  • [Cites] Am J Surg Pathol. 1994 Dec;18(12):1213-23 [7977944.001]
  • [Cites] J Natl Cancer Inst. 1994 Sep 7;86(17):1297-302 [8064888.001]
  • [Cites] Nature. 1993 Jun 17;363(6430):640-4 [8510758.001]
  • [Cites] Hum Pathol. 1997 Feb;28(2):134-42 [9023392.001]
  • [Cites] Am J Surg Pathol. 1997 Mar;21(3):271-81 [9060596.001]
  • [Cites] Cancer Genet Cytogenet. 1997 Nov;99(1):14-8 [9352790.001]
  • [Cites] J Pathol. 1998 Jun;185(2):188-90 [9713346.001]
  • [Cites] Ann Diagn Pathol. 2000 Aug;4(4):252-66 [10982304.001]
  • [Cites] Mod Pathol. 2003 Mar;16(3):256-62 [12640106.001]
  • [Cites] Adv Cancer Res. 2003;89:1-34 [14587869.001]
  • [Cites] Mod Pathol. 2004 Jun;17(6):660-9 [15098008.001]
  • [Cites] J Pathol. 2004 Jul;203(3):822-30 [15221942.001]
  • [Cites] Am J Surg Pathol. 2005 Oct;29(10):1340-7 [16160477.001]
  • [Cites] Genes Chromosomes Cancer. 2006 May;45(5):447-54 [16419059.001]
  • [Cites] Am J Surg Pathol. 2007 Oct;31(10):1476-89 [17895748.001]
  • [Cites] Diagn Cytopathol. 2007 Nov;35(11):734-7 [17924413.001]
  • [Cites] Ultrastruct Pathol. 2008 Mar-Apr;32(2):63-71 [18446669.001]
  • [Cites] Mod Pathol. 2008 Aug;21(8):943-9 [18500263.001]
  • [Cites] Cytopathology. 2009 Jun;20(3):195-8 [18627405.001]
  • [Cites] Mod Pathol. 2009 Jan;22(1):66-70 [18836421.001]
  • [Cites] Cancer Genet Cytogenet. 1986 Dec;23(4):291-9 [3779625.001]
  • (PMID = 20436789.001).
  • [ISSN] 1742-6413
  • [Journal-full-title] CytoJournal
  • [ISO-abbreviation] Cytojournal
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2861822
  • [Keywords] NOTNLM ; Cytopathology / MDM2 / fine needle aspiration biopsy liposarcoma
  •  go-up   go-down


10. Jensen JN, Cameron E, Garay MV, Starkey TW, Gianani R, Jensen J: Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology; 2005 Mar;128(3):728-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To define cell differentiation changes associated with pancreatic regeneration in adult mice, we compared regeneration following caerulein-induced pancreatitis to that of normal pancreatic development.
  • METHODS: By performing comparative histology for adult and embryonic pancreatic markers in caerulein-treated and control pancreas, we addressed cellular proliferation and differentiation (amylase, DBA-agglutinin, insulin, glucagon, beta-catenin, E-cadherin, Pdx1, Nkx6.1, Notch1, Notch2, Jagged1, Jagged2, Hes1), hereby describing the kinetics of tissue restoration.
  • Expression of the Notch target gene Hes1 provides evidence that Notch signaling is reactivated in dedifferentiated pancreatic cells.
  • Although previous studies have suggested a process of acino-to-ductal transdifferentiation in pancreatic regeneration, we find no evidence to suggest that dedifferentiated cells acquire a ductal fate during this process.
  • CONCLUSIONS: Pancreatic regeneration following chemically induced pancreatitis in the mouse occurs predominantly through acinar cell dedifferentiation, whereby a genetic program resembling embryonic pancreatic precursors is reinstated.

  • MedlinePlus Health Information. consumer health - Pancreatitis.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15765408.001).
  • [ISSN] 0016-5085
  • [Journal-full-title] Gastroenterology
  • [ISO-abbreviation] Gastroenterology
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / DK-61248-03; United States / NIDDK NIH HHS / DK / P30 DK57516
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 0 / Membrane Proteins; 0 / Nkx6-1 protein, mouse; 0 / Receptors, Notch; 0 / Trans-Activators; 0 / pancreatic and duodenal homeobox 1 protein; 888Y08971B / Ceruletide
  •  go-up   go-down


11. Mayordomo E, Machado I, Giner F, Kresse SH, Myklebost O, Carda C, Navarro S, Llombart-Bosch A: A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models. Appl Immunohistochem Mol Morphol; 2010 Oct;18(5):453-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Osteosarcomas (OS) are aggressive neoplasms with a wide range of morphologic patterns.
  • A morphologic evaluation including the different passages in mice was carried out according to the new WHO criteria.
  • The distribution of the cases according to the histopathologic pattern was: 38 osteogenic OS, 8 primary chondrogenic OS, 2 primary telangiectatic OS, 6 parosteal OS, 2 primary small cell OS, 2 primary poorly differentiated OS, 1 primary dedifferentiated OS, and 3 primary pleomorphic MFH-like OS.
  • CONCLUSIONS: An accurate morphologic evaluation using TMAs in original tumor is essential for the OS diagnosis; hence there is no IHC marker that alone distinguishes the OS subtypes.

  • Genetic Alliance. consumer health - Osteosarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20436344.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Osteonectin; 104982-03-8 / Osteocalcin
  •  go-up   go-down


12. Liu K, Wang K, Yan H: Incomplete digestion preserves chondrocytes from dedifferentiating in long-termed culture on plastic substrate. Tissue Cell; 2009 Feb;41(1):1-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incomplete digestion preserves chondrocytes from dedifferentiating in long-termed culture on plastic substrate.
  • [MeSH-minor] Animals. Antigens, CD29 / genetics. Cell Differentiation / drug effects. Cell Shape / drug effects. Cells, Cultured. Collagen Type II / genetics. Collagen Type II / metabolism. Epiphyses / cytology. Extracellular Matrix / ultrasonography. Focal Adhesion Protein-Tyrosine Kinases / genetics. Male. Microscopy, Electron, Transmission. Plastics. Rats. Rats, Sprague-Dawley. Transcriptional Activation / drug effects

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18674789.001).
  • [ISSN] 0040-8166
  • [Journal-full-title] Tissue & cell
  • [ISO-abbreviation] Tissue Cell
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Antigens, CD29; 0 / Collagen Type II; 0 / Plastics; EC 2.7.10.2 / Focal Adhesion Protein-Tyrosine Kinases; EC 3.2.1.35 / Hyaluronoglucosaminidase; EC 3.4.24.- / Collagenases
  •  go-up   go-down


13. Pluchino S, Zanotti L, Brini E, Ferrari S, Martino G: Regeneration and repair in multiple sclerosis: the role of cell transplantation. Neurosci Lett; 2009 Jun 12;456(3):101-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cells play a critical role in reparative regeneration as regenerating structures (cells or tissues) depend on the proliferation without (de)differentiation of parenchymal cells surviving to the injury, proliferation of stem (progenitor) cells resident in the injured tissue, dedifferentiation of mature cells in the remaining tissue, or by the influx of stem cells originating outside the damaged tissue.


14. Bakkelund K, Fossmark R, Nordrum I, Waldum H: Signet ring cells in gastric carcinomas are derived from neuroendocrine cells. J Histochem Cytochem; 2006 Jun;54(6):615-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study we examined gastric signet ring cell carcinomas for neuroendocrine differentiation.
  • We propose that signet ring cell carcinomas develop by gradual dedifferentiation from ECL cells via signet ring cells with neuroendocrine immunoreactivity toward signet ring cells where the cytoplasm mainly consists of PAS-positive material.
  • This finding could have implications for the classification and understanding of gastric carcinogenesis.
  • [MeSH-minor] Biomarkers / metabolism. Cell Differentiation. Chromogranin A. Chromogranins / metabolism. Gastric Mucosa / metabolism. Gastric Mucosa / pathology. Histidine Decarboxylase / metabolism. Humans. Synaptophysin / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16344325.001).
  • [ISSN] 0022-1554
  • [Journal-full-title] The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
  • [ISO-abbreviation] J. Histochem. Cytochem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Chromogranin A; 0 / Chromogranins; 0 / Synaptophysin; EC 4.1.1.22 / Histidine Decarboxylase
  •  go-up   go-down


15. Liebig B, Brabletz T, Staege MS, Wulfänger J, Riemann D, Burdach S, Ballhausen WG: Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin. Cancer Lett; 2005 Jun 1;223(1):159-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twenty-eight (58%) of these cases showed over-expression of mesothelin in a small fraction of tumor cells displaying dedifferentiation and dissemination at the invasion front.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15890249.001).
  • [ISSN] 0304-3835
  • [Journal-full-title] Cancer letters
  • [ISO-abbreviation] Cancer Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Cell Adhesion Molecules; 0 / DNA-Binding Proteins; 0 / GPI-Linked Proteins; 0 / HNF1A protein, human; 0 / Hepatocyte Nuclear Factor 1-alpha; 0 / Membrane Glycoproteins; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / mesothelin; 126548-29-6 / Hepatocyte Nuclear Factor 1
  •  go-up   go-down


16. Prakash J, de Borst MH, Lacombe M, Opdam F, Klok PA, van Goor H, Meijer DK, Moolenaar F, Poelstra K, Kok RJ: Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury. J Am Soc Nephrol; 2008 Nov;19(11):2086-97
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Rho kinase pathway plays an important role in dedifferentiation of epithelial cells and infiltration of inflammatory cells.
  • Treatment with Y27632-lysozyme substantially inhibited ischemia/reperfusion-induced tubular damage, indicated by reduced staining of the dedifferentiation markers kidney injury molecule 1 and vimentin, and increased E-cadherin relative to controls.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1998 Feb 13;273(7):4135-42 [9461608.001]
  • [Cites] J Clin Invest. 1994 May;93(5):2175-88 [7910173.001]
  • [Cites] J Am Soc Nephrol. 1998 Oct;9(10):1759-66 [9773776.001]
  • [Cites] J Pharmacol Exp Ther. 1999 Jan;288(1):281-5 [9862782.001]
  • [Cites] Eur J Pharmacol. 2004 Nov 28;505(1-3):205-11 [15556154.001]
  • [Cites] J Am Soc Nephrol. 2005 Jul;16(7):1977-84 [15901767.001]
  • [Cites] Kidney Int Suppl. 2005 Dec;(99):S39-45 [16336575.001]
  • [Cites] J Pharmacol Sci. 2006 Jan;100(1):29-33 [16397371.001]
  • [Cites] J Control Release. 2006 Mar 10;111(1-2):193-203 [16466667.001]
  • [Cites] J Leukoc Biol. 2006 Mar;79(3):539-54 [16365152.001]
  • [Cites] Gastroenterology. 2006 Mar;130(3):838-54 [16530523.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2006 Apr;290(4):R982-91 [16293681.001]
  • [Cites] Nephrol Dial Transplant. 2006 May;21(5):1231-9 [16410269.001]
  • [Cites] Int J Exp Pathol. 2006 Jun;87(3):197-208 [16709228.001]
  • [Cites] J Am Soc Nephrol. 2006 Aug;17(8):2193-201 [16790507.001]
  • [Cites] Am J Physiol Renal Physiol. 2006 Sep;291(3):F606-11 [16525157.001]
  • [Cites] Nat Clin Pract Nephrol. 2005 Dec;1(2):87-97 [16932374.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Oct;319(1):8-19 [16807361.001]
  • [Cites] ChemMedChem. 2006 Nov;1(11):1200-3 [16991175.001]
  • [Cites] Pharm Res. 2008 Oct;25(10):2427-39 [18183478.001]
  • [Cites] Am J Physiol Renal Physiol. 2000 May;278(5):F847-52 [10807598.001]
  • [Cites] Am J Physiol Cell Physiol. 2001 Aug;281(2):C571-8 [11443056.001]
  • [Cites] Urol Clin North Am. 2001 Nov;28(4):793-803, ix [11791495.001]
  • [Cites] Kidney Int. 2002 May;61(5):1684-95 [11967018.001]
  • [Cites] Am J Kidney Dis. 2002 May;39(5):930-6 [11979336.001]
  • [Cites] Transplantation. 2002 Jun 15;73(11):1693-700 [12084988.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1352-9 [12142394.001]
  • [Cites] Am J Physiol Renal Physiol. 2002 Dec;283(6):F1326-36 [12388382.001]
  • [Cites] Eur J Pharmacol. 2002 Nov 29;455(2-3):169-74 [12445583.001]
  • [Cites] Ren Fail. 2002 Nov;24(6):703-23 [12472194.001]
  • [Cites] Curr Opin Nephrol Hypertens. 2003 Jan;12(1):25-9 [12496662.001]
  • [Cites] Immunol Rev. 2003 Apr;192:122-30 [12670400.001]
  • [Cites] J Pharmacol Sci. 2003 Jan;91(1):8-14 [12686725.001]
  • [Cites] Cardiovasc Drugs Ther. 2002 Dec;16(6):489-96 [12766381.001]
  • [Cites] J Immunol. 2003 Jul 1;171(1):96-105 [12816987.001]
  • [Cites] J Pharmacol Sci. 2003 May;92(1):56-69 [12832856.001]
  • [Cites] J Vasc Res. 2003 May-Jun;40(3):244-51 [12902637.001]
  • [Cites] Kidney Int. 2004 Mar;65(3):871-80 [14871406.001]
  • [Cites] Cardiovasc Res. 2004 Feb 15;61(3):548-58 [14962485.001]
  • [Cites] Eur J Pharmacol. 2004 Jun 16;493(1-3):167-71 [15189778.001]
  • [Cites] Biophys J. 2004 Jul;87(1):688-95 [15240502.001]
  • [Cites] Kidney Int. 2004 Aug;66(2):480-5 [15253693.001]
  • [Cites] Kidney Int. 2004 Oct;66(4):1613-21 [15458458.001]
  • [Cites] Arch Biochem Biophys. 2004 Nov 1;431(1):31-46 [15464724.001]
  • [Cites] Semin Nephrol. 1998 Sep;18(5):490-7 [9754601.001]
  • (PMID = 18650485.001).
  • [ISSN] 1533-3450
  • [Journal-full-title] Journal of the American Society of Nephrology : JASN
  • [ISO-abbreviation] J. Am. Soc. Nephrol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Amides; 0 / Ccl2 protein, rat; 0 / Cell Adhesion Molecules; 0 / Chemokine CCL2; 0 / Collagen Type I; 0 / Drug Carriers; 0 / Havcr1protein, rat; 0 / Protein Kinase Inhibitors; 0 / Pyridines; 0 / Tissue Inhibitor of Metalloproteinase-1; 0 / Transforming Growth Factor beta1; 0 / collagen type I, alpha 1 chain; 0 / smooth muscle actin, rat; 138381-45-0 / Y 27632; EC 2.7.11.1 / rho-Associated Kinases; EC 3.2.1.17 / Muramidase
  • [Other-IDs] NLM/ PMC2573003
  •  go-up   go-down


17. Bulycheva IV, Makhson AN, Kuz'min IV, Pavlenko TV: [Dedifferentiated chondrosarcoma: problems of diagnosis and treatment]. Arkh Patol; 2009 Jan-Feb;71(1):46-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Dedifferentiated chondrosarcoma: problems of diagnosis and treatment].
  • The dedifferentiated form of the tumor was confirmed in 10 (13%) cases.
  • Ultrastructural data on the components of dedifferentiated chondrosarcoma are first presented in the Russian literature.
  • Radical surgery remains to be the method of choice in treating patients with dedifferentiated chondrosarcoma; however, the capabilities of multidrug therapy and irradiation should not be ignored in this form of the tumor.

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19514360.001).
  • [ISSN] 0004-1955
  • [Journal-full-title] Arkhiv patologii
  • [ISO-abbreviation] Arkh. Patol.
  • [Language] rus
  • [Publication-type] English Abstract; Lectures
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


18. Germain S, Collette F: Dissociation of perceptual and motor inhibitory processes in young and elderly participants using the Simon task. J Int Neuropsychol Soc; 2008 Nov;14(6):1014-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These results can be interpreted by considering that a dedifferentiation process is responsible for the inhibitory deficits presented by older participants.

  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • COS Scholar Universe. author profiles.
  • ORBi (University of Liege). Free full Text at ORBi .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18954481.001).
  • [ISSN] 1469-7661
  • [Journal-full-title] Journal of the International Neuropsychological Society : JINS
  • [ISO-abbreviation] J Int Neuropsychol Soc
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


19. Shannon BA, Murch A, Cohen RJ: Primary renal synovial sarcoma confirmed by cytogenetic analysis: a lesion distinct from sarcomatoid renal cell carcinoma. Arch Pathol Lab Med; 2005 Feb;129(2):238-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary renal synovial sarcoma confirmed by cytogenetic analysis: a lesion distinct from sarcomatoid renal cell carcinoma.
  • When this occurs, origin of this unusual tumor type has been the subject of debate in the literature, with a suggestion that previously reported cases may be more correctly described as renal cell carcinoma with sarcomatoid dedifferentiation.


20. Huo W, Zhang K, Nie Z, Li Q, Jin F: Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant Rev (Orlando); 2010 Jul;24(3):143-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Kidney injury molecule-1 (KIM-1), a recently discovered transmembrane protein, is expressed in dedifferentiated proximal renal tubular epithelial cells in damaged regions.
  • Many studies have illustrated the different functions of KIM-1 in various renal diseases including protective functions in acute kidney injury and damaging functions in chronic kidney disease.

  • MedlinePlus Health Information. consumer health - Kidney Diseases.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20447817.001).
  • [ISSN] 1557-9816
  • [Journal-full-title] Transplantation reviews (Orlando, Fla.)
  • [ISO-abbreviation] Transplant Rev (Orlando)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / HAVCR1 protein, human; 0 / Membrane Glycoproteins; 0 / Receptors, Virus
  •  go-up   go-down


21. Rinas AC, Ward WG, Kilpatrick SE: Potential sampling error in fine needle aspiration biopsy of dedifferentiated chondrosarcoma: a report of 4 cases. Acta Cytol; 2005 Sep-Oct;49(5):554-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Potential sampling error in fine needle aspiration biopsy of dedifferentiated chondrosarcoma: a report of 4 cases.
  • BACKGROUND: Dedifferentiated chondrosarcoma is a rare, poorly understood and often fatal sarcoma that usually manifests as a high grade, non-cartilage-producing sarcoma juxtaposed against a low grade chondrosarcoma.
  • CASES: We retrospectively reviewed 4 cytology samples (3 primary, 1 metastatic) from 3 patients with dedifferentiated chondrosarcoma, initially analyzed by FNAB, emphasizing the potential for sampling error.
  • One 27-year-old man with multiple osteochondromatosis developed a dedifferentiated chondrosarcoma of the left pelvis.
  • In none of the FNAB or CNB specimens were both low and high grade components of dedifferentiated chondrosarcoma recognized.
  • CONCLUSION: Due to sampling error, the diagnosis of dedifferentiated chondrosarcoma may be difficult to establish by cytologic examination alone.
  • [MeSH-minor] Adult. Aged. Biopsy, Fine-Needle / standards. Cartilage / pathology. Disease Progression. Fatal Outcome. Female. Femur / pathology. Femur / radiography. Humans. Male. Middle Aged. Neoplasm Metastasis. Osteosarcoma / pathology. Pelvis / pathology. Pelvis / radiography. Retrospective Studies. Selection Bias

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16334036.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Matsumoto T, Kano K, Kondo D, Fukuda N, Iribe Y, Tanaka N, Matsubara Y, Sakuma T, Satomi A, Otaki M, Ryu J, Mugishima H: Mature adipocyte-derived dedifferentiated fat cells exhibit multilineage potential. J Cell Physiol; 2008 Apr;215(1):210-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mature adipocyte-derived dedifferentiated fat cells exhibit multilineage potential.
  • When mature adipocytes are subjected to an in vitro dedifferentiation strategy referred to as ceiling culture, these mature adipocytes can revert to a more primitive phenotype and gain cell proliferative ability.
  • We refer to these cells as dedifferentiated fat (DFAT) cells.
  • In the present study, we examined the multilineage differentiation potential of DFAT cells.
  • In vitro differentiation analysis revealed that DFAT cells could differentiate into adipocytes, chondrocytes, and osteoblasts under appropriate culture conditions.
  • In addition, clonally expanded porcine DFAT cells showed the ability to differentiate into multiple mesenchymal cell lineages.
  • [MeSH-major] Adipocytes / cytology. Cell Dedifferentiation. Cell Lineage

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 18064604.001).
  • [ISSN] 1097-4652
  • [Journal-full-title] Journal of cellular physiology
  • [ISO-abbreviation] J. Cell. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Surface
  •  go-up   go-down


23. Nicolas MM, Tamboli P, Gomez JA, Czerniak BA: Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum Pathol; 2010 May;41(5):663-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.
  • In this article, we supplement the few published articles by describing the clinical and pathologic features of pleomorphic and dedifferentiated leiomyosarcoma from 41 patients (27 women and 14 men) with an age range of 25 to 75 years (mean, 56.5 years), representing the largest cohort reported to date.
  • Based on staining for muscle markers in the pleomorphic component, twenty-three cases were designated as pleomorphic leiomyosarcoma, and 7 cases were designated as dedifferentiated leiomyosarcoma (negative for all muscle markers used).
  • Eleven cases, in which tissue was not available for immunhistochemical stains, the question of pleomorphic versus dedifferentiated leiomyosarcoma could not be answered.

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20004935.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers, Tumor; 0 / Calmodulin-Binding Proteins; 0 / Desmin; 0 / Vimentin
  •  go-up   go-down


24. Lluis F, Pedone E, Pepe S, Cosma MP: Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell; 2008 Nov 06;3(5):493-507
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Reprogramming of nuclei allows the dedifferentiation of differentiated cells.
  • Reprogrammed clones express ESC-specific genes, lose somatic differentiation markers, become demethylated on Oct4 and Nanog CpG islands, and can differentiate into cardiomyocytes in vitro and generate teratomas in vivo.

  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cell Stem Cell. 2008 Nov 6;3(5):465-6 [18983957.001]
  • (PMID = 18983965.001).
  • [ISSN] 1875-9777
  • [Journal-full-title] Cell stem cell
  • [ISO-abbreviation] Cell Stem Cell
  • [Language] eng
  • [Grant] Italy / Telethon / / TGM03P10; Italy / Telethon / / TGM06S01
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 6-bromoindirubin-3'-oxime; 0 / Homeodomain Proteins; 0 / Indoles; 0 / Nanog Homeobox Protein; 0 / Nanog protein, mouse; 0 / Octamer Transcription Factor-3; 0 / Oximes; 0 / Wnt Proteins; 0 / Wnt3 Protein; 0 / Wnt3A Protein; 0 / Wnt3a protein, mouse; 0 / beta Catenin; EC 2.7.11.26 / Glycogen Synthase Kinase 3
  •  go-up   go-down


25. Delmaire C, Krainik A, Tézenas du Montcel S, Gerardin E, Meunier S, Mangin JF, Sangla S, Garnero L, Vidailhet M, Lehéricy S: Disorganized somatotopy in the putamen of patients with focal hand dystonia. Neurology; 2005 Apr 26;64(8):1391-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Disease severity correlated with underactivation and decreased distance between right hand and lip representations.
  • In the right putamen, ipsilateral to the affected hand, the somatotopic organization was not altered but disease severity also correlated with reduced distances between limbs.
  • CONCLUSION: In dystonia there may be a dedifferentiation of the normally segregated cortico-subcortical sensorimotor maps in the putamen, which may contribute to the loss of functional selectivity of muscle activity observed in these dystonic subjects.

  • Genetic Alliance. consumer health - Dystonia.
  • Genetic Alliance. consumer health - Focal Dystonia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15851729.001).
  • [ISSN] 1526-632X
  • [Journal-full-title] Neurology
  • [ISO-abbreviation] Neurology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


26. van Timmeren MM, Bakker SJ, Vaidya VS, Bailly V, Schuurs TA, Damman J, Stegeman CA, Bonventre JV, van Goor H: Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol; 2006 Aug;291(2):F456-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Kim-1 expression was limited to areas with inflammation (MØ), fibrosis (alpha-smooth muscle actin), and tubular damage (osteopontin), and only occasionally with tubular dedifferentiation (vimentin).

  • MedlinePlus Health Information. consumer health - Kidney Diseases.
  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16467126.001).
  • [ISSN] 1931-857X
  • [Journal-full-title] American journal of physiology. Renal physiology
  • [ISO-abbreviation] Am. J. Physiol. Renal Physiol.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK072381; United States / NIDDK NIH HHS / DK / DK-39773; United States / NIDDK NIH HHS / DK / DK-72381
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Adhesion Molecules; 0 / Havcr1protein, rat; 0 / Membrane Proteins; 0 / RNA, Messenger; 0 / Vimentin
  •  go-up   go-down


27. Liu Y, Ye F, Li Q, Tamiya S, Darling DS, Kaplan HJ, Dean DC: Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology. Invest Ophthalmol Vis Sci; 2009 Nov;50(11):5080-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose of this study was to investigate the potential role for Zeb1 in EMT leading to the dedifferentiation of retinal pigment epithelial (RPE) cells.
  • METHODS: Real-time PCR was used to examine mRNA expression during RPE dedifferentiation in primary cultures of RPE cells from Zeb1(+/-) mice and after knockdown of Zeb1 by lentivirus shRNA.
  • RESULTS: Zeb1 is overexpressed during RPE dedifferentiation.
  • Heterozygous mutation or shRNA knockdown to prevent this overexpression eliminates the onset of proliferation, loss of epithelial morphology, and pigment, which characterizes RPE dedifferentiation.
  • The authors link Zeb1 expression to cell-cell contact and demonstrate that forcing dedifferentiated RPE cells to adopt cell-cell only contacts via sphere formation reverses the overexpression of Zeb1 and reprograms RPE cells back to a pigmented phenotype.
  • CONCLUSIONS: Overexpression of the EMT transcription factor Zeb1 has an important role in RPE dedifferentiation via its regulation of Mitf.
  • Expression of Zeb1 and, in turn, RPE dedifferentiation, is linked to cell-cell contact, and these contacts can be used to diminish Zeb1 expression and reprogram dedifferentiated RPE cells.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Development. 2004 Oct;131(20):5139-52 [15459106.001]
  • [Cites] Cell. 2008 May 16;133(4):704-15 [18485877.001]
  • [Cites] Arch Ophthalmol. 1995 Jul;113(7):939-44 [7605288.001]
  • [Cites] Acta Anat (Basel). 1995;154(1):8-20 [8714286.001]
  • [Cites] Development. 1998 Jan;125(1):21-31 [9389660.001]
  • [Cites] Mol Cell Biol. 1998 Dec;18(12):6930-8 [9819381.001]
  • [Cites] Curr Eye Res. 1998 Dec;17(12):1103-9 [9872531.001]
  • [Cites] Prog Retin Eye Res. 1999 Mar;18(2):167-90 [9932282.001]
  • [Cites] Mol Cell. 1999 Feb;3(2):169-79 [10078200.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6391-6 [10841546.001]
  • [Cites] Hum Genet. 2000 Jul;107(1):1-6 [10982026.001]
  • [Cites] Genes Dev. 2000 Oct 1;14(19):2393-409 [11018009.001]
  • [Cites] Gene. 2000 Oct 17;257(1):1-12 [11054563.001]
  • [Cites] J Biol Chem. 2000 Dec 1;275(48):37978-83 [10973953.001]
  • [Cites] Ophthalmic Res. 2001 Mar-Apr;33(2):80-6 [11244352.001]
  • [Cites] Development. 2001 Jun;128(11):2019-30 [11493524.001]
  • [Cites] Curr Opin Cell Biol. 2001 Oct;13(5):555-62 [11544023.001]
  • [Cites] Mol Cell. 2002 Feb;9(2):213-24 [11864595.001]
  • [Cites] Curr Opin Genet Dev. 2003 Feb;13(1):77-83 [12573439.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3629-41 [12882817.001]
  • [Cites] Curr Opin Cell Biol. 2003 Dec;15(6):740-6 [14644200.001]
  • [Cites] Gene Expr Patterns. 2003 Dec;3(6):709-17 [14643678.001]
  • [Cites] Cell. 1999 Apr 2;97(1):53-61 [10199402.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6683-8 [10359772.001]
  • [Cites] Development. 2005 Jan;132(1):177-87 [15576400.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):35-40 [15623583.001]
  • [Cites] Dev Cell. 2005 Feb;8(2):179-92 [15691760.001]
  • [Cites] Nature. 2005 Feb 17;433(7027):764-9 [15716956.001]
  • [Cites] Oncogene. 2005 Mar 31;24(14):2375-85 [15674322.001]
  • [Cites] Nat Neurosci. 2005 Oct;8(10):1343-9 [16136043.001]
  • [Cites] Am J Hum Genet. 2005 Nov;77(5):694-708 [16252232.001]
  • [Cites] Exp Eye Res. 2006 Mar;82(3):441-8 [16171805.001]
  • [Cites] Dev Cell. 2006 Jul;11(1):93-104 [16824956.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3612-24 [16877436.001]
  • [Cites] Pigment Cell Res. 2006 Oct;19(5):380-94 [16965267.001]
  • [Cites] Nat Protoc. 2006;1(1):234-40 [17406238.001]
  • [Cites] Cancer Res. 2007 Apr 1;67(7):3450-60 [17409456.001]
  • [Cites] Hum Mutat. 2007 Jun;28(6):638 [17437275.001]
  • [Cites] Mol Cell Biol. 2007 Jun;27(11):3911-9 [17438132.001]
  • [Cites] Pigment Cell Res. 2007 Jun;20(3):173-84 [17516925.001]
  • [Cites] Nat Rev Cancer. 2007 Jun;7(6):415-28 [17508028.001]
  • [Cites] Biochem J. 2007 Nov 15;408(1):79-85 [17655524.001]
  • [Cites] Development. 2008 Feb;135(3):579-88 [18192284.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 May;49(5):1843-9 [18436818.001]
  • [Cites] Mol Cell Biol. 1994 Sep;14(9):5692-700 [8065305.001]
  • (PMID = 19515996.001).
  • [ISSN] 1552-5783
  • [Journal-full-title] Investigative ophthalmology & visual science
  • [ISO-abbreviation] Invest. Ophthalmol. Vis. Sci.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / EY017869; United States / NEI NIH HHS / EY / EY015636; United States / NEI NIH HHS / EY / R24 EY015636; United States / NCRR NIH HHS / RR / P20 RR018733; United States / NEI NIH HHS / EY / EY017869-01A1; United States / NEI NIH HHS / EY / R21 EY017869; United States / NEI NIH HHS / EY / R21 EY017869-02; United States / NEI NIH HHS / EY / R21 EY017869-01A1; United States / NEI NIH HHS / EY / EY017869-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cdkn1a protein, mouse; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Homeodomain Proteins; 0 / Kruppel-Like Transcription Factors; 0 / Melanins; 0 / Microphthalmia-Associated Transcription Factor; 0 / Mitf protein, mouse; 0 / RNA, Messenger; 0 / ZEB1 protein, mouse
  • [Other-IDs] NLM/ NIHMS293893; NLM/ PMC3648851
  •  go-up   go-down


28. Heyse TJ, Malcherczyk D, Moll R, Timmesfeld N, Wapelhorst J, Fuchs-Winkelmann S, Paletta JR, Schofer MD: CD44: survival and metastasis in chondrosarcoma. Osteoarthritis Cartilage; 2010 Jun;18(6):849-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Among the 30 patients (median age 50 years) there were 22 conventional chondrosarcomas, two dedifferentiated chondrosarcomas, two extraskeletal chondrosarcomas, and one periostal, mesenchymal, clear cell and myxoid chondrosarcoma each.

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20171296.001).
  • [ISSN] 1522-9653
  • [Journal-full-title] Osteoarthritis and cartilage
  • [ISO-abbreviation] Osteoarthr. Cartil.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Protein Isoforms
  •  go-up   go-down


29. Fougère-Deschatrette C, Imaizumi-Scherrer T, Strick-Marchand H, Morosan S, Charneau P, Kremsdorf D, Faust DM, Weiss MC: Plasticity of hepatic cell differentiation: bipotential adult mouse liver clonal cell lines competent to differentiate in vitro and in vivo. Stem Cells; 2006 Sep;24(9):2098-109
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Plasticity of hepatic cell differentiation: bipotential adult mouse liver clonal cell lines competent to differentiate in vitro and in vivo.
  • In fetal liver, bipotential hepatoblasts differentiate into hepatocytes and bile duct cells (cholangiocytes).
  • In damaged liver of adult murine animals, when hepatocyte proliferation is compromised, bipotential oval cells emerge, probably from bile ducts, proliferate, and differentiate to regenerate the liver.
  • Although hepatocytes dedifferentiated with loss of apical polarity and other hepatocyte markers, they rapidly activated expression of bile duct/oval cell markers.
  • Furthermore, they can participate in liver regeneration in albumin-urokinase-type plasminogen activator/severe combined immune-deficient mice, where they differentiate in clusters of hepatocytes and occasionally bile ducts.
  • [MeSH-major] Cell Differentiation. Hepatocytes / cytology. Liver / cytology

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16946000.001).
  • [ISSN] 1066-5099
  • [Journal-full-title] Stem cells (Dayton, Ohio)
  • [ISO-abbreviation] Stem Cells
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers
  •  go-up   go-down


30. Coco DP, Hirsch MS, Hornick JL: Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract. Am J Surg Pathol; 2009 Dec;33(12):1795-801
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Smoothelin is a smooth muscle-specific cytoskeletal protein exclusively found in differentiated smooth muscle cells.
  • The purpose of this study was to determine whether immunostaining for smoothelin could help distinguish smooth muscle neoplasms from their morphologic mimics, particularly KIT-negative gastrointestinal stromal tumors (GISTs), desmin-positive GISTs, and desmoid fibromatosis.
  • A total of 150 mesenchymal neoplasms of the GI tract, abdominal cavity, and retroperitoneum were retrieved from consult and surgical pathology archives, including 54 GISTs (8 KIT-negative; 13 desmin-positive), 17 GI leiomyosarcomas (LMS), 11 GI mural leiomyomas, 13 leiomyomas of the muscularis mucosae, 12 gastric schwannomas, 15 inflammatory myofibroblastic tumors, 9 cases of mesenteric desmoid fibromatosis, 10 dedifferentiated liposarcomas, and 9 malignant peripheral nerve sheath tumors.
  • None of the GISTs, desmoid tumors, inflammatory myofibroblastic tumors, schwannomas, dedifferentiated liposarcomas, or malignant peripheral nerve sheath tumors showed cytoplasmic reactivity for smoothelin.
  • These findings suggest that the extent and pattern of smoothelin expression may help differentiate between benign and malignant mesenchymal tumors of the GI tract, and may be useful in distinguishing leiomyomas from KIT-negative and/or desmin-positive GISTs.
  • [MeSH-minor] Cell Differentiation. Cell Nucleus / chemistry. Cytoplasm / chemistry. Desmin / analysis. Diagnosis, Differential. Humans. Immunohistochemistry. Neoplasm Staging. Predictive Value of Tests. Proto-Oncogene Proteins c-kit / analysis. Sensitivity and Specificity

  • COS Scholar Universe. author profiles.
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19950405.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cytoskeletal Proteins; 0 / Desmin; 0 / Muscle Proteins; 0 / SMTN protein, human; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


31. Kipling D, Jones DL, Smith SK, Giles PJ, Jennert-Burston K, Ibrahim B, Sheerin AN, Evans AJ, Rhys-Willams W, Faragher RG: A transcriptomic analysis of the EK1.Br strain of human fibroblastoid keratocytes: the effects of growth, quiescence and senescence. Exp Eye Res; 2009 Feb;88(2):277-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Data mining shows (i) that EK1.Br retain the characteristic transcriptional fingerprint of keratocytes in vitro (ii) that this phenotype can be distinguished from those of other 'fibroblasts' by groups of highly differentially expressed genes and (iii) that senescence induces a distinct dedifferentiation phenomenon in EK1.Br.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19087878.001).
  • [ISSN] 1096-0007
  • [Journal-full-title] Experimental eye research
  • [ISO-abbreviation] Exp. Eye Res.
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / EGH16151
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


32. Kojiro M: Histopathology of liver cancers. Best Pract Res Clin Gastroenterol; 2005 Feb;19(1):39-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most valuable information is that in the majority of cases HCC arises as a very well differentiated cancer and proliferates with a stepwise process of dedifferentiation.
  • However, as many HCCs are still detected at an advanced stage, it is also important to understand not only the classical pathologic features of HCC but also unusual features such as scirrhous change, sarcomatous change, fibrolamellar variant, and intra-bile duct or intra-atrial tumor growth.
  • [MeSH-minor] Bile Duct Neoplasms / pathology. Bile Ducts, Intrahepatic. Cell Differentiation. Cholangiocarcinoma / pathology. Humans. Liver / pathology. Precancerous Conditions / blood supply. Precancerous Conditions / pathology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15757804.001).
  • [ISSN] 1521-6918
  • [Journal-full-title] Best practice & research. Clinical gastroenterology
  • [ISO-abbreviation] Best Pract Res Clin Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 90
  •  go-up   go-down


33. Lopez-Garcia MA, Palacios J: Pathologic and molecular features of uterine carcinosarcomas. Semin Diagn Pathol; 2010 Nov;27(4):274-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although the diagnosis of UCS is not difficult in most cases, the differential diagnosis may include entities such as undifferentiated or dedifferentiated carcinoma, endometrioid adenocarcinoma with spindle cell elements, sarcomatous overgrowth in a low-grade müllerian adenosarcoma, and pure malignant mesenchymal tumors.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21309261.001).
  • [ISSN] 0740-2570
  • [Journal-full-title] Seminars in diagnostic pathology
  • [ISO-abbreviation] Semin Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


34. Paner GP, McKenney JK, Epstein JI, Amin MB: Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol; 2008 Jul;32(7):1022-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
  • We report the clinicopathologic features of 5 bladder neoplasms with rhabdomyosarcomatous differentiation in adults and emphasize the differential diagnosis in the adult setting.
  • Gross hematuria was the most common initial symptom, although 2 patients had metastatic disease at presentation.
  • All 5 cases demonstrated a diffuse growth pattern (ie, non-nested), of which 4 cases had nuclear anaplasia (Wilms criteria without the atypical mitotic figure requirement); only 1 case (the sarcomatoid carcinoma) showed obvious rhabdomyoblastic differentiation (ie, strap cells).
  • The degree of morphologic overlap with small cell carcinoma of the bladder, a relatively more common round cell tumor in adults, was striking.
  • The epithelial component of the sarcomatoid carcinoma was high-grade invasive urothelial carcinoma with glandular differentiation.
  • Outcome data were available in 4 cases, and all 4 died of disease (1, 4, 8, and 8 mo).
  • In conclusion, (1) RMS of the urinary bladder in adults more commonly presents as a primitive round blue cell neoplasm that has significant morphologic and immunohistochemical overlap with small cell carcinoma of the bladder. (2) Although RMS in children generally have a botryoid embryonal histology with favorable outcome, bladder RMS in adults frequently demonstrates alveolar or unclassified histology, commonly with anaplasia, and have a uniformly aggressive clinical course.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anaplasia. Biomarkers, Tumor / analysis. Cell Nucleus / pathology. Combined Modality Therapy. Desmin / analysis. Diagnosis, Differential. Fatal Outcome. Female. Humans. Male. Middle Aged. MyoD Protein / analysis. Myogenin / analysis. Synaptophysin / analysis

  • Genetic Alliance. consumer health - Rhabdomyosarcoma alveolar.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18469707.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Desmin; 0 / MyoD Protein; 0 / MyoD1 myogenic differentiation protein; 0 / Myogenin; 0 / Synaptophysin
  •  go-up   go-down


35. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN: MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev; 2009 Sep 15;23(18):2166-78
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Vascular injury triggers dedifferentiation and cytoskeletal remodeling of smooth muscle cells (SMCs), culminating in vessel occlusion.
  • Mice lacking both miR-143 and miR-145 are viable and do not display overt abnormalities in smooth muscle differentiation, although they show a significant reduction in blood pressure due to reduced vascular tone.
  • Thus, miR-143 and miR-145 act as integral components of the regulatory network whereby SRF controls cytoskeletal remodeling and phenotypic switching of SMCs during vascular disease.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • SciCrunch. Marmoset Gene list: Data: Gene Annotation .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13027-32 [18723672.001]
  • [Cites] Nat Genet. 2006 Feb;38(2):228-33 [16380711.001]
  • [Cites] J Cell Sci. 2009 Jan 1;122(Pt 1):13-20 [19092056.001]
  • [Cites] Nat Cell Biol. 2009 Mar;11(3):257-68 [19198601.001]
  • [Cites] Circ Res. 2009 Mar 27;104(6):724-32 [19325160.001]
  • [Cites] J Biol Chem. 2009 Apr 3;284(14):9549-57 [19189969.001]
  • [Cites] Circulation. 2009 Apr 28;119(16):2217-24 [19398677.001]
  • [Cites] Nat Cell Biol. 2009 May;11(5):545-56 [19329994.001]
  • [Cites] Cell. 2009 May 15;137(4):647-58 [19409607.001]
  • [Cites] Science. 2009 Jun 26;324(5935):1710-3 [19460962.001]
  • [Cites] Circ Res. 2009 Jul 17;105(2):158-66 [19542014.001]
  • [Cites] Nature. 2009 Aug 6;460(7256):705-10 [19578358.001]
  • [Cites] Development. 2000 Dec;127(24):5331-41 [11076755.001]
  • [Cites] Cell. 2001 Jun 29;105(7):851-62 [11439182.001]
  • [Cites] Cell. 2001 Oct 19;107(2):209-21 [11672528.001]
  • [Cites] J Mol Cell Cardiol. 2002 Oct;34(10):1345-56 [12392995.001]
  • [Cites] Mol Cell Biol. 2003 Apr;23(7):2425-37 [12640126.001]
  • [Cites] Circ Res. 2003 May 2;92(8):856-64 [12663482.001]
  • [Cites] Cell. 2003 May 2;113(3):329-42 [12732141.001]
  • [Cites] J Cell Biol. 2003 May 12;161(3):557-70 [12743105.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7129-34 [12756293.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9366-70 [12867591.001]
  • [Cites] Cell. 2004 Jan 23;116(2):281-97 [14744438.001]
  • [Cites] Nature. 2004 Mar 11;428(6979):185-9 [15014501.001]
  • [Cites] Nature. 1987 Jul 23-29;328(6128):359-62 [3600811.001]
  • [Cites] Lab Invest. 1993 Jan;68(1):89-99 [8423679.001]
  • [Cites] Biotech Histochem. 1994 Sep;69(5):289-90 [7819424.001]
  • [Cites] Physiol Rev. 1995 Jul;75(3):487-517 [7624392.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2238-44 [9351395.001]
  • [Cites] Cell. 1998 Apr 17;93(2):215-28 [9568714.001]
  • [Cites] Development. 1999 May;126(10):2045-52 [10207130.001]
  • [Cites] Genes Dev. 2006 Jun 15;20(12):1545-56 [16778073.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11189-94 [16847256.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18255-60 [17108080.001]
  • [Cites] Am J Physiol Cell Physiol. 2007 Jan;292(1):C70-81 [16928770.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1170-80 [16997888.001]
  • [Cites] Circ Res. 2007 Mar 16;100(5):633-44 [17363709.001]
  • [Cites] Nat Med. 2007 Apr;13(4):486-91 [17401374.001]
  • [Cites] Science. 2007 Apr 27;316(5824):575-9 [17379774.001]
  • [Cites] Mol Cell. 2007 Jul 6;27(1):91-105 [17612493.001]
  • [Cites] J Clin Invest. 2007 Sep;117(9):2369-76 [17786230.001]
  • [Cites] Science. 2007 Oct 12;318(5848):271-4 [17761850.001]
  • [Cites] Curr Opin Cell Biol. 2007 Dec;19(6):618-27 [18023168.001]
  • [Cites] Circ Res. 2008 Feb 29;102(4):432-8 [18096821.001]
  • [Cites] Circ Res. 2008 Jun 20;102(12):1548-57 [18483411.001]
  • [Cites] Dev Cell. 2008 Aug;15(2):261-71 [18694565.001]
  • [Cites] Cardiovasc Res. 2008 Sep 1;79(4):551-2 [18614548.001]
  • [Cites] J Biochem. 2008 Sep;144(3):313-21 [18511453.001]
  • [Cites] J Cell Biol. 1999 Apr 19;145(2):347-61 [10209029.001]
  • [Cites] Mol Cell Biol. 2005 Apr;25(8):3173-81 [15798203.001]
  • [Cites] Nat Genet. 2005 May;37(5):495-500 [15806104.001]
  • [Cites] J Thromb Haemost. 2005 Aug;3(8):1569-76 [16102021.001]
  • [Cites] Genes Dev. 2008 Dec 1;22(23):3242-54 [19015276.001]
  • (PMID = 19720868.001).
  • [ISSN] 1549-5477
  • [Journal-full-title] Genes & development
  • [ISO-abbreviation] Genes Dev.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / MIRN145 microRNA, mouse; 0 / MKL1 protein, mouse; 0 / MicroRNAs; 0 / Mirn143 microRNA, mouse; 0 / Nuclear Proteins; 0 / Trans-Activators; 0 / myocardin
  • [Other-IDs] NLM/ PMC2751981
  •  go-up   go-down


36. Suzuki Y, Squires DC, Riddiford LM: Larval leg integrity is maintained by Distal-less and is required for proper timing of metamorphosis in the flour beetle, Tribolium castaneum. Dev Biol; 2009 Feb 1;326(1):60-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Apparently, the partial dedifferentiation of the appendages in these larvae acts to maintain high JH and, hence, prevents metamorphosis.

  • Hazardous Substances Data Bank. METHOPRENE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dev Biol. 1967 Nov;16(5):438-56 [6053287.001]
  • [Cites] Biol Bull. 1972 Apr;142(2):281-92 [5021128.001]
  • [Cites] J Exp Biol. 1974 Oct;61(2):481-91 [4443740.001]
  • [Cites] J Exp Biol. 1974 Oct;61(2):493-501 [4443741.001]
  • [Cites] Nature. 1976 Jan 15;259(5539):115-7 [1246347.001]
  • [Cites] J Embryol Exp Morphol. 1976 Apr;35(2):303-21 [939941.001]
  • [Cites] Development. 1994 Dec;120(12):3473-86 [7821215.001]
  • [Cites] Arch Insect Biochem Physiol. 1996;32(3-4):271-86 [8756300.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 May 13;94(10):5162-6 [9144208.001]
  • [Cites] Dev Genes Evol. 2005 Feb;215(2):78-89 [15647943.001]
  • [Cites] Evol Dev. 2005 Mar-Apr;7(2):89-100 [15733306.001]
  • [Cites] Annu Rev Entomol. 2005;50:181-99 [15355237.001]
  • [Cites] Dev Biol. 2007 May 15;305(2):539-50 [17418115.001]
  • [Cites] Int J Biochem Cell Biol. 2007;39(6):1105-18 [17317270.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10488-93 [17537916.001]
  • [Cites] J Econ Entomol. 2007 Jun;100(3):627-45 [17598520.001]
  • [Cites] Insect Biochem Mol Biol. 2007 Aug;37(8):761-70 [17628276.001]
  • [Cites] Development. 2008 Feb;135(3):569-77 [18171684.001]
  • [Cites] FEBS J. 2008 Jun;275(11):2919-31 [18435763.001]
  • [Cites] Mech Dev. 2008 Jul;125(7):601-16 [18450431.001]
  • [Cites] J Insect Physiol. 2008 Jun;54(6):895-901 [18355835.001]
  • [Cites] Development. 2000 Jan;127(2):209-16 [10603339.001]
  • [Cites] Development. 2000 Sep;127(17):3683-94 [10934013.001]
  • [Cites] Development. 2001 Jan;128(2):287-97 [11124123.001]
  • [Cites] Dev Genes Evol. 2001 Oct;211(10):467-77 [11702196.001]
  • [Cites] Annu Rev Entomol. 2002;47:467-500 [11729082.001]
  • [Cites] Development. 2002 Apr;129(8):1967-74 [11934862.001]
  • [Cites] Dev Growth Differ. 2004 Apr;46(2):115-29 [15066191.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4877-82 [15041751.001]
  • [Cites] Dev Biol. 2004 Jul 15;271(2):306-21 [15223336.001]
  • (PMID = 19022238.001).
  • [ISSN] 1095-564X
  • [Journal-full-title] Developmental biology
  • [ISO-abbreviation] Dev. Biol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM060122-32; United States / NIGMS NIH HHS / GM / R01 GM060122; United States / NIGMS NIH HHS / GM / 2R01 GM60122; United States / NIGMS NIH HHS / GM / R01 GM060122-31; United States / NIGMS NIH HHS / GM / GM060122-31; United States / NIGMS NIH HHS / GM / R01 GM060122-32
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 0 / RNA, Double-Stranded; 0 / Transcription Factors; 0 / distal-less protein, insect; 8B830OJ2UX / Methoprene
  • [Other-IDs] NLM/ NIHMS93807; NLM/ PMC2762819
  •  go-up   go-down


37. Letavernier E, Bruneval P, Mandet C, Duong Van Huyen JP, Péraldi MN, Helal I, Noël LH, Legendre C: High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol; 2007 Mar;2(2):326-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High sirolimus levels may induce focal segmental glomerulosclerosis de novo.
  • However, nephrotic syndrome and FSGS were observed recently in three patients who received sirolimus de novo, without medical history of primary FSGS or CAN.
  • Markers of podocyte differentiation were studied in kidney biopsies of the three patients who received sirolimus de novo and of five patients who switched to sirolimus.
  • Immunohistochemistry showed that some podocytes in FSGS lesions had absent or diminished expression of the podocyte-specific epitopes synaptopodin and p57, reflecting dedifferentiation, and had acquired expression of cytokeratin and PAX2, reflecting a immature fetal phenotype.

  • Genetic Alliance. consumer health - Focal Segmental Glomerulosclerosis.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • Hazardous Substances Data Bank. SIROLIMUS .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Clin J Am Soc Nephrol. 2007 Mar;2(2):198-9 [17699406.001]
  • (PMID = 17699432.001).
  • [ISSN] 1555-905X
  • [Journal-full-title] Clinical journal of the American Society of Nephrology : CJASN
  • [ISO-abbreviation] Clin J Am Soc Nephrol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunosuppressive Agents; W36ZG6FT64 / Sirolimus
  •  go-up   go-down


38. Chen NX, Moe SM: Uremic vascular calcification. J Investig Med; 2006 Nov;54(7):380-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We identified increased expression of bone-associated proteins (osteopontin, bone sialoprotein, alkaline phosphatase, type I collagen) and the bone-specific transcription factor core-binding factor alpha(1) (Cbfalpha(1)) in histologic sections of inferior epigastric arteries obtained from patients with stage V chronic kidney disease or calcific uremic arteriolopathy.
  • This implies that the uremic mileau may lead to dedifferentiation of vascular smooth muscle cells, with subsequent mineralization.
  • Further understanding of the pathophysiology of uremic vascular calcification is needed to design effective therapeutic strategies to intervene with this devastating condition in patients with stage V chronic kidney disease.

  • MedlinePlus Health Information. consumer health - Vascular Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17169259.001).
  • [ISSN] 1081-5589
  • [Journal-full-title] Journal of investigative medicine : the official publication of the American Federation for Clinical Research
  • [ISO-abbreviation] J. Investig. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / AHSG protein, human; 0 / Blood Proteins; 0 / Core Binding Factor Alpha 1 Subunit; 0 / RUNX2 protein, human; 0 / alpha-2-HS-Glycoprotein
  •  go-up   go-down


39. Zheng JP, Ju D, Jiang H, Shen J, Yang M, Li L: Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation. Toxicol Lett; 2010 Nov 30;199(2):115-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation.
  • However, little is known about how RSVL affects vascular smooth muscle cells (VSMCs) differentiation.
  • Thus, one might expect that RSVL will promote VSMC differentiation.
  • In an effort to identify the molecular mechanisms whereby RSVL represses VSMC differentiation, we found that RSVL inhibits the transcription of Myocardin (myocd) and Srf, the key VSMC transcriptional regulators.
  • However, knockingdown and overexpressing p53 did not affect RSVL-induced VSMCs phenotypic modulation: this suggests that RSVL may induce VSMC dedifferentiation via p53-independent mechanisms.
  • This study provides the first evidence showing that RSVL induces VSMC dedifferentiation by regulating Myocardin and SRF-mediated VSMC gene transcription.

  • Hazardous Substances Data Bank. RESVERATROL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
  • [Cites] Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H859-66 [18065527.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1263-9 [18420994.001]
  • [Cites] PLoS One. 2008;3(11):e3707 [19002260.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1027-37 [19168719.001]
  • [Cites] Arch Biochem Biophys. 2009 Jun 15;486(2):95-102 [19514131.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1164-71 [19478208.001]
  • [Cites] Exp Cell Res. 2009 Oct 15;315(17):2953-62 [19665018.001]
  • [Cites] J Thorac Cardiovasc Surg. 2009 Dec;138(6):1392-9 [19931668.001]
  • [Cites] Cardiovasc Res. 2010 Feb 1;85(3):514-9 [19815564.001]
  • [Cites] Exp Mol Pathol. 2010 Feb;88(1):52-7 [19874818.001]
  • [Cites] J Vasc Res. 2010;47(2):168-80 [19851078.001]
  • [Cites] J Pharmacol Exp Ther. 2010 Apr;333(1):34-42 [20089806.001]
  • [Cites] Dev Cell. 2010 Apr 20;18(4):510-25 [20412767.001]
  • [Cites] Circ Res. 2010 Apr 30;106(8):1351-62 [20224039.001]
  • [Cites] Biochem Pharmacol. 2000 Apr 1;59(7):865-70 [10718345.001]
  • [Cites] J Immunol. 2000 Jun 15;164(12):6509-19 [10843709.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Jul 21;274(1):61-7 [10903896.001]
  • [Cites] J Clin Invest. 2000 Nov;106(9):1139-47 [11067866.001]
  • [Cites] Cell. 2001 Jun 29;105(7):851-62 [11439182.001]
  • [Cites] Biochem Pharmacol. 2001 Oct 15;62(8):1113-24 [11597580.001]
  • [Cites] Circulation. 2002 Sep 24;106(13):1652-8 [12270858.001]
  • [Cites] Thromb Res. 2002 Aug 15;107(3-4):141-5 [12431480.001]
  • [Cites] Circ Res. 2003 May 2;92(8):856-64 [12663482.001]
  • [Cites] Nature. 2003 Sep 11;425(6954):191-6 [12939617.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Nov 14;311(2):546-52 [14592451.001]
  • [Cites] Biochem Pharmacol. 2004 Feb 15;67(4):777-85 [14757178.001]
  • [Cites] Circ Res. 2004 Apr 16;94(7):863-5 [15044321.001]
  • [Cites] Curr Opin Genet Dev. 2004 Oct;14(5):558-66 [15380248.001]
  • [Cites] Circulation. 1992 Dec;86(6):1977-86 [1333373.001]
  • [Cites] Lancet. 1993 Feb 20;341(8843):454-7 [8094487.001]
  • [Cites] J Clin Invest. 1994 Jun;93(6):2393-402 [8200973.001]
  • [Cites] J Cell Biol. 1996 Mar;132(5):849-59 [8603917.001]
  • [Cites] Dev Biol. 1997 Jul 15;187(2):311-21 [9242426.001]
  • [Cites] Toxicol Sci. 2004 Dec;82(2):614-9 [15329443.001]
  • [Cites] Circ Res. 2005 Feb 18;96(3):280-91 [15718508.001]
  • [Cites] J Biol Chem. 2005 Mar 11;280(10):9719-27 [15623517.001]
  • [Cites] Eur J Pharmacol. 2005 May 16;515(1-3):1-9 [15878161.001]
  • [Cites] J Nutr. 2005 Dec;135(12):2767-73 [16317118.001]
  • [Cites] J Vasc Surg. 2005 Dec;42(6):1190-7 [16376213.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Jul 21;346(1):367-76 [16759640.001]
  • [Cites] J Intern Med. 2006 Sep;260(3):192-210 [16918817.001]
  • [Cites] Development. 2006 Nov;133(21):4245-56 [17021041.001]
  • [Cites] Am J Physiol Cell Physiol. 2007 Jan;292(1):C70-81 [16928770.001]
  • [Cites] Circ Res. 2007 Mar 16;100(5):607-21 [17363707.001]
  • [Cites] BMC Genomics. 2007;8:237 [17634102.001]
  • [Cites] Arch Med Res. 2008 Feb;39(2):155-61 [18164958.001]
  • [Cites] Recent Pat Cardiovasc Drug Discov. 2007 Jun;2(2):133-8 [18221111.001]
  • (PMID = 20797428.001).
  • [ISSN] 1879-3169
  • [Journal-full-title] Toxicology letters
  • [ISO-abbreviation] Toxicol. Lett.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / HL087014-04; United States / NHLBI NIH HHS / HL / R01 HL087014; United States / NHLBI NIH HHS / HL / HL087014; United States / NHLBI NIH HHS / HL / R01 HL087014-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Nuclear Proteins; 0 / Serum Response Factor; 0 / Stilbenes; 0 / Trans-Activators; 0 / Tumor Suppressor Protein p53; 0 / myocardin; Q369O8926L / resveratrol
  • [Other-IDs] NLM/ NIHMS231778; NLM/ PMC3155942
  •  go-up   go-down


40. Bi D, Nishimura J, Niiro N, Hirano K, Kanaide H: Contractile properties of the cultured vascular smooth muscle cells: the crucial role played by RhoA in the regulation of contractility. Circ Res; 2005 Apr 29;96(8):890-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Vascular smooth muscle cells (VSMCs) have a remarkable degree of plasticity and in response to vascular injury, they can change to a dedifferentiated state that can be typically seen in cell cultures.

  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15774857.001).
  • [ISSN] 1524-4571
  • [Journal-full-title] Circulation research
  • [ISO-abbreviation] Circ. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amides; 0 / Myosin Light Chains; 0 / Pyridines; 138381-45-0 / Y 27632; 37589-80-3 / Guanosine 5'-O-(3-Thiotriphosphate); EC 2.7.11.13 / Protein Kinase C; EC 3.6.5.2 / rhoA GTP-Binding Protein; SY7Q814VUP / Calcium
  •  go-up   go-down


41. Ondrej V, Navrátilová B, Protivánková I, Piterková J, Sedlárová M, Luhová L, Lebeda A: Recondensation level of repetitive sequences in the plant protoplast nucleus is limited by oxidative stress. J Exp Bot; 2010 May;61(9):2395-401
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Protoplast cultures are remarkable examples of plant cell dedifferentiation.
  • The state of dedifferentiation is evidenced by changes in cell morphology, genome organization, as well as by the capability of protoplasts to differentiate into multiple types of cells (depending on the type of the stimulus applied).
  • The first change in the genome structure is connected with large-scale chromatin decondensation, affecting chromocentres involving various types of these repetitive sequences.
  • This paper describes not only the de- and recondensation of satellite DNA type I and 5S rDNA repetitive sequences, but it also compares the recondensation level of chromatin with the levels of oxidative stress which were decreased by using an antioxidant, as well as the capabilities of the antioxidative systems within protoplasts, during the first 72 h of their culture.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Fluoresc. 2006 Jan;16(1):119-39 [16477509.001]
  • [Cites] J Cell Sci. 2007 Apr 1;120(Pt 7):1200-8 [17376962.001]
  • [Cites] Plant Physiol Biochem. 2007 Aug;45(8):607-16 [17629488.001]
  • [Cites] Curr Opin Plant Biol. 2008 Feb;11(1):64-9 [18024147.001]
  • [Cites] Mol Cells. 2008 Oct 31;26(4):356-61 [18612243.001]
  • [Cites] Mol Cells. 2009 Apr 30;27(4):443-7 [19390825.001]
  • [Cites] Exp Cell Res. 2004 May 15;296(1):86-90 [15120998.001]
  • [Cites] Eur J Biochem. 2000 Aug;267(16):5078-84 [10931190.001]
  • [Cites] Plant Physiol. 2000 Sep;124(1):17-20 [10982417.001]
  • [Cites] J Biol Chem. 2001 Jun 22;276(25):22772-8 [11274191.001]
  • [Cites] Plant Physiol. 2002 May;129(1):40-9 [12011336.001]
  • [Cites] Cell Mol Biol Lett. 2002;7(3):849-58 [12378268.001]
  • [Cites] Dev Biol. 2004 Apr 1;268(1):1-6 [15031100.001]
  • [Cites] Trends Biotechnol. 2009 Jun;27(6):329-32 [19395104.001]
  • (PMID = 20363868.001).
  • [ISSN] 1460-2431
  • [Journal-full-title] Journal of experimental botany
  • [ISO-abbreviation] J. Exp. Bot.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Plant Proteins; EC 1.11.1.- / Peroxidases; EC 1.11.1.11 / Ascorbate Peroxidases; EC 1.11.1.6 / Catalase
  • [Other-IDs] NLM/ PMC2877892
  •  go-up   go-down


42. Petersson F, Michal M, Franco M, Hes O: Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation - report of a unique case. Int J Clin Exp Pathol; 2010;3(5):534-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation - report of a unique case.
  • Of the published cases with sarcomatous transformation of CRCC, none have shown liposarcomatous differentiation.
  • Out of a cohort of 250 cases of CRCC, 19 (7.6%) showed sarcomatous differentiation.
  • The patient died from widespread metastatic disease 12 months after nephrectomy.

  • Genetic Alliance. consumer health - Chromophobe Renal Cell Carcinoma.
  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 2000 Feb;36(2):184-5 [10733322.001]
  • [Cites] Int J Surg Pathol. 2010 Oct;18(5):419-23 [19098016.001]
  • [Cites] Pathol Res Pract. 2000;196(9):647-51; discussion 652 [10997740.001]
  • [Cites] Arch Esp Urol. 2000 Oct;53(8):700-7 [11126971.001]
  • [Cites] Am J Surg Pathol. 2001 Mar;25(3):275-84 [11224597.001]
  • [Cites] Int J Cancer. 2002 May 1;99(1):68-73 [11948494.001]
  • [Cites] Pathol Oncol Res. 2002;8(2):142-4 [12172580.001]
  • [Cites] BJU Int. 2002 Oct;90(6):529-32 [12230610.001]
  • [Cites] Am J Surg Pathol. 2002 Oct;26(10):1358-62 [12360051.001]
  • [Cites] Ann Diagn Pathol. 2003 Oct;7(5):296-9 [14571432.001]
  • [Cites] Am J Surg Pathol. 2004 Apr;28(4):435-41 [15087662.001]
  • [Cites] Urol Oncol. 2004 Sep-Oct;22(5):425-7 [15464925.001]
  • [Cites] Virchows Arch B Cell Pathol Incl Mol Pathol. 1985;48(3):207-17 [2859694.001]
  • [Cites] Gen Diagn Pathol. 1997 Jul;143(1):63-9 [9269910.001]
  • [Cites] Am J Surg Pathol. 1997 Oct;21(10):1188-95 [9331291.001]
  • [Cites] Pathol Int. 1998 Oct;48(10):812-7 [9788266.001]
  • [Cites] APMIS. 1998 Oct;106(10):993-6 [9833703.001]
  • [Cites] Ann Diagn Pathol. 1998 Jun;2(3):149-53 [9845733.001]
  • [Cites] Cesk Patol. 1999 Jan;35(1):15-9 [10379058.001]
  • [Cites] Histopathology. 1999 Jun;34(6):557-9 [10383704.001]
  • [Cites] Mod Pathol. 2004 Dec;17(12):1455-63 [15286660.001]
  • [Cites] Virchows Arch. 2005 Apr;446(4):383-93 [15756595.001]
  • [Cites] Am J Surg Pathol. 2005 Oct;29(10):1340-7 [16160477.001]
  • [Cites] Int J Urol. 2005 Sep;12(9):835-7 [16201981.001]
  • [Cites] Arch Esp Urol. 2006 Mar;59(2):209-14 [16649532.001]
  • [Cites] Mod Pathol. 2007 Mar;20(3):303-9 [17277768.001]
  • [Cites] Am J Surg Pathol. 2007 May;31(5):770-3 [17460462.001]
  • [Cites] Histopathology. 2008 Feb;52(3):283-93 [18269578.001]
  • [Cites] Cancer Genet Cytogenet. 2008 Jul 15;184(2):99-104 [18617058.001]
  • [Cites] Mod Pathol. 2009 Sep;22(9):1196-200 [19525929.001]
  • [Cites] Arch Pathol Lab Med. 2009 Nov;133(11):1857-60 [19886723.001]
  • [CommentIn] Int J Clin Exp Pathol. 2010;3(7):742 [20830247.001]
  • (PMID = 20606735.001).
  • [ISSN] 1936-2625
  • [Journal-full-title] International journal of clinical and experimental pathology
  • [ISO-abbreviation] Int J Clin Exp Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC2897100
  • [Keywords] NOTNLM ; Chromophobe renal cell carcinoma / liposarcoma / sarcomatoid / sarcomatous transformation
  •  go-up   go-down


43. Reiff T, Tsarovina K, Majdazari A, Schmidt M, del Pino I, Rohrer H: Neuroblastoma phox2b variants stimulate proliferation and dedifferentiation of immature sympathetic neurons. J Neurosci; 2010 Jan 20;30(3):905-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neuroblastoma phox2b variants stimulate proliferation and dedifferentiation of immature sympathetic neurons.
  • Together, these results suggest that PHOX2B mutations predispose to neuroblastoma by increasing proliferation and promoting dedifferentiation of cells in the sympathoadrenergic lineage.
  • [MeSH-major] Cell Differentiation / physiology. Cell Proliferation. Ganglia, Sympathetic / cytology. Homeodomain Proteins / physiology. Mutation / physiology. Transcription Factors / physiology
  • [MeSH-minor] Animals. Basic Helix-Loop-Helix Transcription Factors / genetics. Basic Helix-Loop-Helix Transcription Factors / metabolism. Brain-Derived Neurotrophic Factor / pharmacology. Bromodeoxyuridine / metabolism. Cell Count / methods. Cell Line, Tumor. Cells, Cultured. Chick Embryo. Embryo, Mammalian. Gene Expression Regulation, Developmental / drug effects. Gene Expression Regulation, Developmental / genetics. Gene Expression Regulation, Neoplastic / genetics. Green Fluorescent Proteins / genetics. Histones / metabolism. Immunoprecipitation. Inhibitor of Differentiation Protein 2 / genetics. Inhibitor of Differentiation Protein 2 / metabolism. Mice. Mice, Inbred C57BL. Neuroblastoma. Neurons. RNA, Small Interfering / pharmacology. Tyrosine 3-Monooxygenase / metabolism

  • Genetics Home Reference. consumer health - neuroblastoma.
  • Genetics Home Reference. consumer health - PHOX2B gene.
  • Hazardous Substances Data Bank. BROMODEOXYURIDINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20089899.001).
  • [ISSN] 1529-2401
  • [Journal-full-title] The Journal of neuroscience : the official journal of the Society for Neuroscience
  • [ISO-abbreviation] J. Neurosci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Basic Helix-Loop-Helix Transcription Factors; 0 / Brain-Derived Neurotrophic Factor; 0 / Hand2 protein, mouse; 0 / Histones; 0 / Homeodomain Proteins; 0 / Idb2 protein, mouse; 0 / Inhibitor of Differentiation Protein 2; 0 / NBPhox protein; 0 / RNA, Small Interfering; 0 / Transcription Factors; 147336-22-9 / Green Fluorescent Proteins; EC 1.14.16.2 / Tyrosine 3-Monooxygenase; G34N38R2N1 / Bromodeoxyuridine
  •  go-up   go-down


44. Weaver J, Downs-Kelly E, Goldblum JR, Turner S, Kulkarni S, Tubbs RR, Rubin BP, Skacel M: Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol; 2008 Aug;21(8):943-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Well-differentiated liposarcoma/atypical lipomatous tumor and dedifferentiated liposarcoma can be difficult to distinguish from benign lipomatous neoplasms and other high-grade sarcomas, respectively.
  • Dual color fluorescence in situ hybridization employing a laboratory-developed BAC label probe cocktail specific for MDM2 (12q15) and a probe for the centromeric region of chromosome 12 (Abbott Molecular, DesPlaines, IL) was performed on formalin-fixed and paraffin-embedded tissue including whole sections from atypical lipomatous tumors (n=13), dedifferentiated liposarcomas (n=14), benign lipomatous tumors (n=30), and pleomorphic sarcoma, not otherwise specified (n=10), and a tissue microarray containing a variety of high-grade sarcomas (n=63).
  • Of the well-differentiated and dedifferentiated liposarcomas, 100% showed amplification of MDM2.
  • The specificity decreases in high-grade sarcomas, as MDM2 amplification was observed in a small portion of pleomorphic sarcomas and high-grade sarcomas other than dedifferentiated liposarcomas.
  • Importantly, none of the benign lipomatous lesions were MDM2 amplified and even cells in areas of well-differentiated liposarcomas with minimal cytologic atypia were amplified, making the probe a valuable tool in the diagnosis of even limited biopsy samples of well-differentiated lipomatous neoplasms.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18500263.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 6.3.2.19 / MDM2 protein, human; EC 6.3.2.19 / Proto-Oncogene Proteins c-mdm2
  •  go-up   go-down


45. Italiano A, Maire G, Sirvent N, Nuin PA, Keslair F, Foa C, Louis C, Aurias A, Pedeutour F: Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas. Cancer Lett; 2009 Jan 18;273(2):323-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas.
  • Well-differentiated liposarcomas (WDLPS) and dedifferentiated liposarcomas are cytogenetically characterized by the presence of supernumerary ring or giant chromosomes containing amplified material from the 12q14-15 region.


46. Ambrosini G, Cheema HS, Seelman S, Teed A, Sambol EB, Singer S, Schwartz GK: Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. Mol Cancer Ther; 2008 Apr;7(4):890-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MPNST (MPNST and ST8814) and dedifferentiated liposarcoma (LS141 and DDLS) human tumor cell lines were characterized for Ras activation and B-Raf expression.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. NICOTINAMIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 1999 Dec;155(6):1885-91 [10595919.001]
  • [Cites] Mol Cancer Ther. 2007 Mar;6(3):1070-8 [17363500.001]
  • [Cites] Cancer Res. 2002 Mar 1;62(5):1573-7 [11894862.001]
  • [Cites] Nature. 2002 Jun 27;417(6892):949-54 [12068308.001]
  • [Cites] N Engl J Med. 2002 Aug 15;347(7):472-80 [12181401.001]
  • [Cites] Curr Pharm Des. 2002;8(25):2255-7 [12369853.001]
  • [Cites] Leukemia. 2003 Jul;17(7):1263-93 [12835716.001]
  • [Cites] Cancer Cell. 2003 Aug;4(2):95-8 [12957284.001]
  • [Cites] Cancer Res. 2003 Sep 1;63(17):5198-202 [14500344.001]
  • [Cites] Clin Cancer Res. 2004 Jun 1;10(11):3763-71 [15173083.001]
  • [Cites] Cancer Res. 2004 Oct 1;64(19):7099-109 [15466206.001]
  • [Cites] Cancer Cell. 2004 Oct;6(4):313-9 [15488754.001]
  • [Cites] Cell. 1992 Apr 17;69(2):265-73 [1568246.001]
  • [Cites] Nature. 1992 Apr 23;356(6371):713-5 [1570015.001]
  • [Cites] J Biol Chem. 1996 Aug 23;271(34):20608-16 [8702807.001]
  • [Cites] Development. 1998 Dec;125(24):4999-5008 [9811584.001]
  • [Cites] Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S69-77 [15316751.001]
  • [Cites] Cancer Res. 2005 Jan 1;65(1):236-45 [15665300.001]
  • [Cites] Mol Cancer Ther. 2005 Apr;4(4):677-85 [15827342.001]
  • [Cites] N Engl J Med. 2005 Aug 18;353(7):701-11 [16107623.001]
  • [Cites] Nature. 2006 Jan 19;439(7074):358-62 [16273091.001]
  • [Cites] J Biol Chem. 2006 Apr 7;281(14):9238-50 [16452469.001]
  • [Cites] Clin Cancer Res. 2006 Sep 15;12(18):5533-42 [17000690.001]
  • [Cites] Trends Mol Med. 2002 Jan;8(1):17-23 [11796262.001]
  • (PMID = 18413802.001).
  • [ISSN] 1535-7163
  • [Journal-full-title] Molecular cancer therapeutics
  • [ISO-abbreviation] Mol. Cancer Ther.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P01 CA047179-16; United States / NCI NIH HHS / CA / T32 CA009501-18; United States / NCI NIH HHS / CA / T32 CA009501; United States / NCI NIH HHS / CA / T32 CA009501-17; United States / NCI NIH HHS / CA / P01 CA047179-17; United States / NCI NIH HHS / CA / CA09501; United States / NCI NIH HHS / CA / P01 CA047179
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzenesulfonates; 0 / Phenylurea Compounds; 0 / Pyridines; 0 / Retinoblastoma Protein; 136601-57-5 / Cyclin D1; 25X51I8RD4 / Niacinamide; 9ZOQ3TZI87 / sorafenib; EC 2.7.11.1 / BRAF protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins B-raf; EC 2.7.11.1 / Proto-Oncogene Proteins c-raf; EC 2.7.11.22 / CDK4 protein, human; EC 2.7.11.22 / Cyclin-Dependent Kinase 4; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; EC 2.7.11.24 / Mitogen-Activated Protein Kinases; EC 2.7.12.2 / Mitogen-Activated Protein Kinase Kinases; EC 3.6.5.2 / ras Proteins
  • [Other-IDs] NLM/ NIHMS349129; NLM/ PMC3267321
  •  go-up   go-down


47. Xu AM, Gong SJ, Song WH, Li XW, Pan CH, Zhu JJ, Wu MC: Primary mixed germ cell tumor of the liver with sarcomatous components. World J Gastroenterol; 2010 Feb 7;16(5):652-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The predominant components of immature teratoma consisted of several types of tissue that represented different germinal layers (endoderm, mesoderm and ectoderm) and showed varying degrees of differentiation with significant sarcomatous components.
  • The immature teratoma components showed positivity for varying differentiation markers.
  • This suggested that sarcomatous components may be associated with dedifferentiation or malignant transformation of certain mesenchymal components within teratoma.

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gastroenterol Hepatol. 1999 Dec;14(12):1227-9 [10634163.001]
  • [Cites] World J Gastroenterol. 2009 Sep 28;15(36):4587-92 [19777620.001]
  • [Cites] Hepatogastroenterology. 2001 Mar-Apr;48(38):424-6 [11379323.001]
  • [Cites] Acta Med Austriaca. 2003;30(1):26-8 [12558563.001]
  • [Cites] Histopathology. 2003 Sep;43(3):306-8 [12940789.001]
  • [Cites] J Clin Oncol. 2004 May 1;22(9):1756-8 [15118001.001]
  • [Cites] Radiographics. 2004 Sep-Oct;24(5):1467-71 [15371619.001]
  • [Cites] Virchows Arch. 1998 Jul;433(1):93-6 [9692832.001]
  • [Cites] World J Gastroenterol. 2007 Feb 7;13(5):809-12 [17278210.001]
  • [Cites] Am J Surg Pathol. 2007 Sep;31(9):1356-62 [17721191.001]
  • [Cites] Transpl Int. 2008 Jun;21(6):598-601 [18363574.001]
  • [Cites] Cancer Res. 2008 Jun 1;68(11):4239-47 [18519683.001]
  • [Cites] World J Gastroenterol. 2009 Feb 28;15(8):1014-7 [19248205.001]
  • [Cites] Am J Surg Pathol. 2009 Aug;33(8):1173-8 [19561445.001]
  • [Cites] Hum Pathol. 2000 Aug;31(8):938-44 [10987254.001]
  • (PMID = 20128038.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / alpha-Fetoproteins
  • [Other-IDs] NLM/ PMC2816282
  •  go-up   go-down


48. Legraverend M, Grierson DS: The purines: potent and versatile small molecule inhibitors and modulators of key biological targets. Bioorg Med Chem; 2006 Jun 15;14(12):3987-4006
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Purine-based compounds have found new applications as inducers of interferon and lineage-committed cell dedifferentiation, agonists and antagonists of adenosine receptors, ligands of corticotropin-releasing hormone receptors, and as inhibitors of HSP90, Src kinase, p38alpha MAP kinase, sulfotransferases, phosphodiesterases, and Cdks.
  • [MeSH-minor] Cell Differentiation / drug effects. Humans. Ligands. Molecular Structure. Structure-Activity Relationship

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16503144.001).
  • [ISSN] 0968-0896
  • [Journal-full-title] Bioorganic & medicinal chemistry
  • [ISO-abbreviation] Bioorg. Med. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / Enzyme Inhibitors; 0 / Ligands; 0 / Purines
  • [Number-of-references] 169
  •  go-up   go-down


49. Decraene C, Benchaouir R, Dillies MA, Israeli D, Bortoli S, Rochon C, Rameau P, Pitaval A, Tronik-Le Roux D, Danos O, Gidrol X, Garcia L, Piétu G: Global transcriptional characterization of SP and MP cells from the myogenic C2C12 cell line: effect of FGF6. Physiol Genomics; 2005 Oct 17;23(2):132-49
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Expression profiles of SPs show that these cells are less differentiated than MPs and display some similarities to stem cells.
  • Moreover, principal component analysis made it possible to distinguish specific contributions of either FGF6 or differentiation effects on gene expression profiles.
  • We propose that FGF6 conditioning could provide a way to expand the pool of immature cells by myoblast dedifferentiation.
  • [MeSH-minor] Animals. Benzimidazoles. Cell Differentiation. Cell Separation. Cells, Cultured. DNA / metabolism. DNA Probes. Down-Regulation / genetics. Flow Cytometry. Gene Expression Profiling. Mice. Microarray Analysis. Principal Component Analysis. Reproducibility of Results. Reverse Transcriptase Polymerase Chain Reaction. Staining and Labeling. Up-Regulation / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16033864.001).
  • [ISSN] 1531-2267
  • [Journal-full-title] Physiological genomics
  • [ISO-abbreviation] Physiol. Genomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Benzimidazoles; 0 / DNA Probes; 0 / Fgf6 protein, mouse; 0 / Fibroblast Growth Factor 6; 0 / Proto-Oncogene Proteins; 23491-52-3 / HOE 33342; 9007-49-2 / DNA
  •  go-up   go-down


50. Baeyens L, Bonné S, German MS, Ravassard P, Heimberg H, Bouwens L: Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/STAT pathway. Cell Death Differ; 2006 Nov;13(11):1892-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study demonstrates that in vitro growth factor stimulation can induce recapitulation of an embryonic endocrine differentiation pathway in adult dedifferentiated exocrine cells.

  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • Hazardous Substances Data Bank. NICOTINAMIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16514419.001).
  • [ISSN] 1350-9047
  • [Journal-full-title] Cell death and differentiation
  • [ISO-abbreviation] Cell Death Differ.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK021344
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Basic Helix-Loop-Helix Transcription Factors; 0 / Growth Substances; 0 / Hepatocyte Nuclear Factor 6; 0 / Nerve Tissue Proteins; 0 / Neurog3 protein, rat; 0 / RNA, Messenger; 0 / STAT3 Transcription Factor; 25X51I8RD4 / Niacinamide; EC 2.7.10.2 / Janus Kinase 2; EC 3.1.1.3 / Lipase
  •  go-up   go-down


51. Chinnaiyan P, Wang M, Rojiani AM, Tofilon PJ, Chakravarti A, Ang KK, Zhang HZ, Hammond E, Curran W Jr, Mehta MP: The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group. Radiat Oncol; 2008;3:32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Based on the heterogeneous expression of nestin in GBM and its potential to serve as a marker for a dedifferentiated, and perhaps more aggressive phenotype, the Radiation Therapy Oncology Group (RTOG) sought to determine the prognostic value of nestin expression in newly diagnosed GBM patients treated on prior prospective RTOG clinical trials.
  • [MeSH-minor] Antineoplastic Agents, Alkylating / therapeutic use. Cell Lineage. Combined Modality Therapy / methods. Dacarbazine / analogs & derivatives. Dacarbazine / therapeutic use. Disease-Free Survival. Humans. Nestin. Neurons / metabolism. Phenotype. Prognosis. Research Design. Treatment Outcome

  • Genetic Alliance. consumer health - Glioblastoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. DACARBAZINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Biol Cell. 2003 Apr;14(4):1468-78 [12686602.001]
  • [Cites] Surg Neurol. 2007 Aug;68(2):133-43; discussion 143-4 [17537489.001]
  • [Cites] J Neurosci. 1985 Dec;5(12):3310-28 [4078630.001]
  • [Cites] Cell. 1990 Feb 23;60(4):585-95 [1689217.001]
  • [Cites] J Biol Chem. 2001 May 11;276(19):16456-63 [11278541.001]
  • [Cites] J Neurooncol. 2008 Jan;86(1):31-45 [17611714.001]
  • [Cites] J Clin Pathol. 2008 Apr;61(4):467-73 [17873113.001]
  • [Cites] J Biol Chem. 2004 Jul 2;279(27):27994-9 [15117961.001]
  • [Cites] Curr Opin Neurol. 2001 Dec;14(6):683-8 [11723374.001]
  • [Cites] Lab Invest. 2002 Mar;82(3):345-51 [11896213.001]
  • [Cites] Lab Invest. 1992 Mar;66(3):303-13 [1538585.001]
  • [Cites] Cancer Res. 1992 Oct 1;52(19):5334-41 [1382841.001]
  • [Cites] Cell Mol Life Sci. 2004 Oct;61(19-20):2510-22 [15526158.001]
  • [Cites] Nature. 2004 Nov 18;432(7015):396-401 [15549107.001]
  • [Cites] J Clin Pathol. 2005 Feb;58(2):222-3 [15677549.001]
  • [Cites] N Engl J Med. 2005 Mar 10;352(10):987-96 [15758009.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):318-27 [15890570.001]
  • [Cites] Neurosci Lett. 2006 May 29;400(1-2):80-5 [16529857.001]
  • [Cites] EMBO J. 2006 Oct 18;25(20):4808-19 [17036052.001]
  • [Cites] Front Biosci. 2007;12:2252-9 [17127461.001]
  • [Cites] Nature. 2006 Dec 7;444(7120):756-60 [17051156.001]
  • [Cites] Mod Pathol. 2007 Jan;20(1):102-7 [17143262.001]
  • [Cites] Cancer Res. 2007 Jan 15;67(2):501-10 [17234757.001]
  • [Cites] J Cutan Pathol. 2007 May;34(5):370-5 [17448190.001]
  • [Cites] Cancer Biol Ther. 2007 Jul;6(7):1018-24 [17611402.001]
  • (PMID = 18817556.001).
  • [ISSN] 1748-717X
  • [Journal-full-title] Radiation oncology (London, England)
  • [ISO-abbreviation] Radiat Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Intermediate Filament Proteins; 0 / NES protein, human; 0 / Nerve Tissue Proteins; 0 / Nes protein, mouse; 0 / Nestin; 7GR28W0FJI / Dacarbazine; 85622-93-1 / temozolomide
  • [Other-IDs] NLM/ PMC2563009
  •  go-up   go-down


52. Padron Velazquez JL: Stem cell fusion as an ultimate line of defense against xenobiotics. Med Hypotheses; 2006;67(2):383-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • By fusing with somatic de-differentiated cells, stem cells might consent epigenetic reprogramming and/or genetic recovery of genes which otherwise could drive altered cells to malignancy.
  • If the many sophisticated mechanisms of metabolism, cell repair, programmed cell death and tissue regeneration should fail, stem cells might represent a final attempt to recover dedifferentiated cells to avoid inflowing in cancer.
  • [MeSH-minor] Animals. Apoptosis. Cell Differentiation. Cell Fusion. Humans. Mutation. Regeneration

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16527429.001).
  • [ISSN] 0306-9877
  • [Journal-full-title] Medical hypotheses
  • [ISO-abbreviation] Med. Hypotheses
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Xenobiotics
  •  go-up   go-down


53. Teruya-Feldstein J, Gopalan A, Moskowitz CH: CD5 negative, Cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleen. Appl Immunohistochem Mol Morphol; 2009 May;17(3):255-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor cells showed marked pleomorphism, anaplasia, and increased mitotic figures with positive Cyclin D1, BCL6, MUM1, P53, and a high MIB1 proliferative fraction.
  • This case raises the differential diagnoses of pleomorphic mantle cell lymphoma and other aggressive lymphomas with pleomorphic, anaplastic, and Reed-Sternberg-like cells.

  • Genetic Alliance. consumer health - Large B cell diffuse lymphoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18838919.001).
  • [ISSN] 1533-4058
  • [Journal-full-title] Applied immunohistochemistry & molecular morphology : AIMM
  • [ISO-abbreviation] Appl. Immunohistochem. Mol. Morphol.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD5; 0 / Tumor Suppressor Protein p53; 136601-57-5 / Cyclin D1; EC 6.3.2.19 / MIB1 ligase, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


54. Hommell-Fontaine J, Borda A, Ragage F, Berger N, Decaussin-Petrucci M: Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma. Virchows Arch; 2010 Jun;456(6):661-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma.
  • The presence of pleomorphic tumor giant cells in thyroid carcinomas of follicular cell origin is always worrisome for the pathologist as they first of all refer to anaplastic carcinoma, one of the most aggressive human malignancies.
  • However, non-anaplastic pleomorphic giant cells are well described in other thyroid diseases, most often benign.
  • In this paper, we describe four cases of papillary thyroid carcinoma displaying pleomorphic tumor giant cells with features that differ from those of anaplastic carcinoma.
  • Compared to pleomorphic giant cells of anaplastic carcinoma, they reproduced the growth pattern of the underlying carcinoma, had a low mitotic index without necrosis or inflammation, and were reactive with thyroglobulin and thyroid-specific transcription factor-1 and strongly and diffusely positive for cytokeratin AE1/AE3.
  • These cases show that pleomorphic tumor giant cells arising in papillary thyroid carcinomas do not always represent dedifferentiation and progression to anaplastic carcinoma.

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diagn Cytopathol. 2009 Jun;37(6):455-65 [19306421.001]
  • [Cites] Endocr J. 2003 Apr;50(2):173-7 [12803237.001]
  • [Cites] Am J Surg Pathol. 1997 Nov;21(11):1261-70 [9351564.001]
  • [Cites] Cancer. 1990 Jul 15;66(2):321-30 [1695118.001]
  • [Cites] Am J Clin Pathol. 1997 Jan;107(1):20-5 [8980362.001]
  • [Cites] Endocr Pathol. 2004 Winter;15(4):319-27 [15681856.001]
  • [Cites] Surgery. 1991 Dec;110(6):956-61; discussion 961-3 [1745983.001]
  • [Cites] Histopathology. 1994 Mar;24(3):205-10 [8200621.001]
  • [Cites] Arch Pathol Lab Med. 1978 Sep;102(9):445-7 [210736.001]
  • [Cites] Histopathology. 2005 Oct;47(4):391-401 [16178894.001]
  • [Cites] Acta Cytol. 2002 Sep-Oct;46(5):823-7 [12365214.001]
  • [Cites] Mod Pathol. 2001 Apr;14(4):338-42 [11301350.001]
  • [Cites] Endocr Pathol. 2006 Spring;17(1):1-18 [16760576.001]
  • [Cites] J Pathol. 1997 Jan;181(1):80-6 [9072007.001]
  • [Cites] World J Surg. 1999 Sep;23(9):975-8; discussion 978-9 [10449831.001]
  • [Cites] Hum Pathol. 2000 Sep;31(9):1139-45 [11014583.001]
  • [Cites] Am J Surg Pathol. 1980 Aug;4(4):333-41 [6999920.001]
  • [Cites] Acta Cytol. 1996 Nov-Dec;40(6):1184-8 [8960026.001]
  • [Cites] Histopathology. 2002 Sep;41(3):236-43 [12207785.001]
  • [Cites] Pathol Res Pract. 2008;204(3):191-5 [18037575.001]
  • [Cites] Hum Pathol. 2008 Jul;39(7):1080-7 [18495207.001]
  • [Cites] Endocr Pathol. 1997 Winter;8(4):283-292 [12114789.001]
  • [Cites] World J Surg. 2001 May;25(5):617-22 [11369989.001]
  • [Cites] Anticancer Res. 1998 Jul-Aug;18(4A):2637-41 [9703921.001]
  • [Cites] Am J Surg Pathol. 2007 Aug;31(8):1256-64 [17667551.001]
  • [Cites] Arch Pathol Lab Med. 2002 Jun;126(6):710-3 [12033961.001]
  • [Cites] Am J Clin Pathol. 2006 Mar;125(3):399-406 [16613343.001]
  • [Cites] Surgery. 2002 Mar;131(3):245-8 [11894027.001]
  • [Cites] Hum Pathol. 2003 Jul;34(7):666-9 [12874762.001]
  • [Cites] Histopathology. 2007 Jan;50(2):225-31 [17222251.001]
  • [Cites] Mod Pathol. 2005 Jan;18(1):48-57 [15272279.001]
  • [Cites] Am J Surg Pathol. 1994 Oct;18(10):1054-64 [7522412.001]
  • [Cites] Diagn Cytopathol. 1999 Nov;21(5):307-12 [10527475.001]
  • [Cites] Ann Endocrinol (Paris). 2008 Jun;69(3):174-80 [18423422.001]
  • [Cites] Am J Clin Pathol. 1996 Dec;106(6):765-8 [8980352.001]
  • [Cites] Am J Clin Pathol. 1985 Feb;83(2):135-58 [2578727.001]
  • [Cites] Ann Surg Oncol. 2002 Jan-Feb;9(1):57-64 [11833496.001]
  • [Cites] Am J Clin Pathol. 1991 Jul;96(1):15-24 [1712540.001]
  • [Cites] Int Surg. 2001 Apr-Jun;86(2):117-21 [11918236.001]
  • [Cites] Cancer Res. 1994 Sep 1;54(17 ):4744-9 [8062273.001]
  • [Cites] J Clin Oncol. 1999 Nov;17(11):3494-502 [10550147.001]
  • [Cites] Cancer. 1999 Jun 1;85(11):2475-84 [10357421.001]
  • [Cites] Cancer. 1978 Jun;41(6):2267-75 [657091.001]
  • (PMID = 20414675.001).
  • [ISSN] 1432-2307
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / TTF1 protein, human; 68238-35-7 / Keratins
  •  go-up   go-down


55. Imataki O, Ohnishi H, Yamaoka G, Arai T, Kitanaka A, Kubota Y, Kushida Y, Ishida T, Tanaka T: Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse. Int J Clin Oncol; 2010 Feb;15(1):112-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Residual disease was proved by biopsy and pathologically shown to have an immature phenotype of CD5+, CD10-, CD20-, CD79a- and myeloperoxidase negativity.
  • This case suggests that leukemic subclones tend to carry out dedifferentiation, occasionally in extramedullary sites, which serve as a hotbed for the selection of resistant clones.

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Leukemia. 1995 Dec;9(12):2023-6 [8609712.001]
  • [Cites] Nat Rev Cancer. 2005 Apr;5(4):311-21 [15803157.001]
  • [Cites] Br J Haematol. 1987 Mar;65(3):261-4 [3552021.001]
  • [Cites] Leuk Lymphoma. 2005 Aug;46(8):1223-7 [16085566.001]
  • [Cites] Blood. 1984 Sep;64(3):701-6 [6590097.001]
  • [Cites] Blood. 1989 Nov 1;74(6):2088-95 [2553159.001]
  • [Cites] Haematologica. 2004 Aug;89(8):ECR28 [15339697.001]
  • [Cites] Cancer Genet Cytogenet. 2006 Jan 15;164(2):118-21 [16434313.001]
  • [Cites] Am J Hematol. 2000 Sep;65(1):72-4 [10936868.001]
  • [Cites] Clin Haematol. 1986 Aug;15(3):811-27 [3536242.001]
  • [Cites] Blood Rev. 1988 Mar;2(1):9-15 [3289656.001]
  • [Cites] Cancer Genet Cytogenet. 2006 Jul 15;168(2):146-9 [16843104.001]
  • [Cites] Br J Haematol. 1993 May;84(1):49-60 [7687860.001]
  • (PMID = 20066454.001).
  • [ISSN] 1437-7772
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


61. Lewis GP, Chapin EA, Luna G, Linberg KA, Fisher SK: The fate of Müller's glia following experimental retinal detachment: nuclear migration, cell division, and subretinal glial scar formation. Mol Vis; 2010 Jul 15;16:1361-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, a subpopulation of anti-BrdU-labeled cells, presumably once Müller cells, appears to stop expressing well accepted Müller cell marker proteins, suggesting a potential dedifferentiation of some of these cells over time.

  • MedlinePlus Health Information. consumer health - Retinal Detachment.
  • MedlinePlus Health Information. consumer health - Scars.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. BROMODEOXYURIDINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Prog Retin Eye Res. 2005 May;24(3):395-431 [15708835.001]
  • [Cites] Ophthalmology. 2004 Dec;111(12):2240-5 [15582080.001]
  • [Cites] Mol Vis. 2005;11:491-500 [16052164.001]
  • [Cites] Exp Eye Res. 2005 Aug;81(2):123-37 [15916760.001]
  • [Cites] Int J Clin Pract. 2005 Oct;59(10):1157-61 [16178982.001]
  • [Cites] Ophthalmology. 2007 Apr;114(4):698-704 [17398320.001]
  • [Cites] J Neurosci. 2007 Jun 27;27(26):7028-40 [17596452.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Feb;49(2):511-21 [18234993.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1262-73 [18326757.001]
  • [Cites] J Cell Sci. 2009 Aug 15;122(Pt 16):2914-23 [19638410.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4429-35 [19369237.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1028-35 [19815730.001]
  • [Cites] Am J Ophthalmol. 1991 Jan 15;111(1):8-14 [1985496.001]
  • [Cites] Retina. 2000;20(5):459-64 [11039419.001]
  • [Cites] Retina. 2000;20(5):465-8 [11039420.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2001 May;42(6):1363-9 [11328752.001]
  • [Cites] Vision Res. 2003 Apr;43(8):887-97 [12668058.001]
  • [Cites] Glia. 2003 Jul;43(1):70-6 [12761869.001]
  • [Cites] Mol Neurobiol. 2003 Oct;28(2):159-75 [14576454.001]
  • [Cites] Am J Ophthalmol. 1980 Jul;90(1):81-5 [7395961.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1986 Feb;27(2):168-83 [3943943.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1991 May;32(6):1739-48 [2032796.001]
  • [Cites] Am J Ophthalmol. 1991 Aug 15;112(2):159-65 [1867299.001]
  • [Cites] Ophthalmology. 1992 Feb;99(2):257-62 [1553218.001]
  • [Cites] Retina. 1992;12(1):52-8 [1565872.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1995 Mar;36(3):737-44 [7890504.001]
  • [Cites] Retina. 1994;14(5):417-24 [7899716.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1995 Nov;36(12):2404-16 [7591630.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1996 Nov;234(11):677-82 [8950587.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1996 Dec;234(12):739-43 [8986445.001]
  • [Cites] Curr Eye Res. 2005 May;30(5):395-403 [16020270.001]
  • (PMID = 20664798.001).
  • [ISSN] 1090-0535
  • [Journal-full-title] Molecular vision
  • [ISO-abbreviation] Mol. Vis.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / R01 EY000888; United States / NEI NIH HHS / EY / R01EY000888
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Vimentin; G34N38R2N1 / Bromodeoxyuridine
  • [Other-IDs] NLM/ PMC2905639
  •  go-up   go-down


62. Martínez-Jiménez CP, Gómez-Lechón MJ, Castell JV, Jover R: Underexpressed coactivators PGC1alpha and SRC1 impair hepatocyte nuclear factor 4 alpha function and promote dedifferentiation in human hepatoma cells. J Biol Chem; 2006 Oct 6;281(40):29840-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Underexpressed coactivators PGC1alpha and SRC1 impair hepatocyte nuclear factor 4 alpha function and promote dedifferentiation in human hepatoma cells.
  • Overexpression of SRC1 and PGC1alpha by recombinant adenoviruses led to a significant up-regulation of well characterized HNF4alpha-dependent genes (ApoCIII, ApoAV, PEPCK, AldoB, OTC, and CYP7A1) and forced HepG2 cells toward a more differentiated phenotype as demonstrated by increased ureogenic rate.
  • The down-regulation of key HNF4alpha coactivators could be a determinant factor for the dedifferentiation of human hepatomas.
  • [MeSH-minor] Adult. Aged. Cell Differentiation / physiology. Cell Line, Tumor. Female. Homeostasis / physiology. Humans. Liver / metabolism. Male. Middle Aged. Nuclear Receptor Coactivator 1


63. Song T, Shen J, Liang BL, Mai WW, Li Y, Guo HC: Retroperitoneal liposarcoma: MR characteristics and pathological correlative analysis. Abdom Imaging; 2007 Sep-Oct;32(5):668-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Well-differentiated liposarcoma (n = 5) presented in high signal intensity on T1W images, intermediate signal intensity on T2W images, drop-out signal intensity on fat-suppressed MR images; The enhanced tenuous septa and solid tissues were seen on post-contrast image.
  • Dedifferentiated liposarcoma (n = 3) exhibited small amounts of fatty components with a clear demarcation between fat and nonadipose solid tissue on MR images.
  • One case of dedifferentiated liposarcoma invaded the kidney.

  • Genetic Alliance. consumer health - Liposarcoma.
  • Genetic Alliance. consumer health - Retroperitoneal liposarcoma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17387533.001).
  • [ISSN] 0942-8925
  • [Journal-full-title] Abdominal imaging
  • [ISO-abbreviation] Abdom Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


64. Okuda I, Ubara Y, Okuda C, Fujii T, Suwabe T, Kokubo T, Nakajima Y, Hashimoto M: A large calcified retroperitoneal mass in a patient with chronic renal failure: liposarcoma with ossification. Clin Exp Nephrol; 2010 Apr;14(2):185-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The calcified mass was surgically resected and histopathologically diagnosed as myxoid-type liposarcoma composed of dedifferentiated, myxoid, and well-differentiated components with areas of osseous metaplasia.

  • Genetic Alliance. consumer health - Liposarcoma.
  • Genetic Alliance. consumer health - Retroperitoneal liposarcoma.
  • MedlinePlus Health Information. consumer health - Kidney Failure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 2003 Sep-Oct;27(5):799-804 [14501373.001]
  • [Cites] J Nucl Med Technol. 1999 Mar;27(1):45-7 [10322576.001]
  • [Cites] Arch Surg. 1993 Jul;128(7):737-44; discussion 744-5 [8317954.001]
  • [Cites] Am J Surg Pathol. 1997 Mar;21(3):271-81 [9060596.001]
  • [Cites] Int J Dermatol. 1996 Apr;35(4):265-71 [8786184.001]
  • [Cites] Cancer. 1990 Jun 15;65(12):2762-70 [2160317.001]
  • [Cites] J Surg Oncol. 2004 May 1;86(2):107-13 [15112254.001]
  • [Cites] Am J Surg Pathol. 1994 Dec;18(12):1213-23 [7977944.001]
  • (PMID = 19882203.001).
  • [ISSN] 1437-7799
  • [Journal-full-title] Clinical and experimental nephrology
  • [ISO-abbreviation] Clin. Exp. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


65. von Bueren AO, Shalaby T, Rajtarova J, Stearns D, Eberhart CG, Helson L, Arcaro A, Grotzer MA: Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells. BMC Cancer; 2007;7:19
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In MB, over-expression of c-MYC has been shown to correlate with anaplasia and unfavorable prognosis.

  • Genetic Alliance. consumer health - Medulloblastoma.
  • Genetic Alliance. consumer health - Medulloblastoma, childhood.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathology. 1999 Nov;31(4):337-44 [10643003.001]
  • [Cites] Cancer Res. 1990 Feb 1;50(3):587-91 [1967549.001]
  • [Cites] Oncogene. 2002 Mar 27;21(13):2058-65 [11960378.001]
  • [Cites] Nat Rev Cancer. 2002 Oct;2(10):764-76 [12360279.001]
  • [Cites] Leukemia. 2002 Nov;16(11):2275-84 [12399973.001]
  • [Cites] Clin Cancer Res. 2004 Feb 1;10(3):1170-9 [14871997.001]
  • [Cites] J Nat Prod. 2004 Feb;67(2):269-72 [14987068.001]
  • [Cites] Lancet Oncol. 2004 Apr;5(4):209-18 [15050952.001]
  • [Cites] Cancer Res. 1990 Apr 15;50(8):2347-50 [2180567.001]
  • [Cites] Cancer Res. 1990 May 15;50(10):2987-90 [2334901.001]
  • [Cites] Tumori. 1991 Apr 30;77(2):118-21 [2048223.001]
  • [Cites] Cancer Res. 1991 Sep 1;51(17):4721-3 [1873817.001]
  • [Cites] Am J Surg Pathol. 1992 Jul;16(7):687-93 [1530108.001]
  • [Cites] J Neurooncol. 1995;24(1):39-45 [8523074.001]
  • [Cites] J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):18-25 [9482408.001]
  • [Cites] J Clin Oncol. 1998 Jul;16(7):2478-85 [9667267.001]
  • [Cites] Oncogene. 1999 May 13;18(19):2934-41 [10378690.001]
  • [Cites] Oncogene. 1999 May 13;18(19):2967-87 [10378693.001]
  • [Cites] Mol Cell. 1999 Aug;4(2):199-207 [10488335.001]
  • [Cites] Cell Death Differ. 2004 Dec;11 Suppl 2:S216-8 [15608695.001]
  • [Cites] Cancer Lett. 2005 Mar 18;220(1):37-48 [15737686.001]
  • [Cites] J Virol. 2005 Aug;79(16):10308-29 [16051824.001]
  • [Cites] Cancer Res. 2006 Jan 15;66(2):673-81 [16423996.001]
  • [Cites] Int J Cancer. 2000 Sep 20;89(5):395-402 [11008200.001]
  • [Cites] Oncogene. 2000 Sep 21;19(40):4604-10 [11030149.001]
  • [Cites] Nat Med. 2001 Feb;7(2):235-9 [11175856.001]
  • [Cites] Curr Biol. 2001 Apr 17;11(8):558-68 [11369200.001]
  • [Cites] Clin Cancer Res. 2001 Aug;7(8):2425-33 [11489822.001]
  • [Cites] Eur J Cancer. 2002 Jan;38(1):83-91 [11750844.001]
  • [Cites] Brain Pathol. 2002 Jan;12(1):36-44 [11770900.001]
  • [Cites] Methods. 2001 Dec;25(4):386-401 [11846608.001]
  • [Cites] Arch Pathol Lab Med. 2002 May;126(5):540-4 [11958658.001]
  • [Cites] Genes Dev. 2004 Jun 1;18(11):1331-44 [15175264.001]
  • [Cites] J Neuropathol Exp Neurol. 2004 May;63(5):441-9 [15198123.001]
  • [Cites] Nature. 2004 Oct 28;431(7012):1112-7 [15475948.001]
  • [Cites] Mol Pharmacol. 1976 Jan;12(1):167-76 [1256442.001]
  • [Cites] Eur J Biochem. 1976 Sep 15;68(2):355-64 [976261.001]
  • [Cites] J Pharm Sci. 1979 Jul;68(7):883-7 [458610.001]
  • [Cites] Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1843-7 [526918.001]
  • [Cites] Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1929-32 [526926.001]
  • [Cites] Cancer Treat Rep. 1981 Sep-Oct;65(9-10):883-5 [7273023.001]
  • [Cites] Am J Clin Oncol. 1982 Aug;5(4):389-91 [7113961.001]
  • [Cites] Invest New Drugs. 1983;1(3):239-42 [6678872.001]
  • [Cites] Nature. 1987 Jul 30-Aug 5;328(6129):445-9 [3302722.001]
  • [Cites] Mol Cell Biol. 1988 Feb;8(2):963-73 [3280975.001]
  • [Cites] Cell. 1989 Sep 22;58(6):1097-105 [2673543.001]
  • [Cites] Clin Cancer Res. 2000 Feb;6(2):452-9 [10690523.001]
  • (PMID = 17254356.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Growth Inhibitors; 0 / MYCBP protein, human; 0 / Quassins; 0 / Transcription Factors
  • [Other-IDs] NLM/ PMC1794252
  •  go-up   go-down


66. Chen X, Li Z, Hu X, Kusuoka Y: Morphology, morphogenesis and gene sequence of a freshwater ciliate, Pseudourostyla cristata (Ciliophora, Urostyloidea) from the ancient Lake Biwa, Japan. Eur J Protistol; 2010 Jan;46(1):43-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • (1) the oral primordium for the proter originates de novo on the dorsal wall of the buccal cavity, and the dedifferentiated undulating membranes and some parental proximal membranelles join in the primordial development; the old adoral zone will be partly replaced by new structures;.
  • (3) the fronto-midventral transverse cirral (FVT) anlagen develop separately in both dividers by dedifferentiation of most of the midventral cirri;.

  • SILVA. SILVA SSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2008 Elsevier GmbH. All rights reserved.
  • (PMID = 19775875.001).
  • [ISSN] 1618-0429
  • [Journal-full-title] European journal of protistology
  • [ISO-abbreviation] Eur. J. Protistol.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ FJ598608
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / RNA, Ribosomal
  •  go-up   go-down


67. Saeki H, Tamada Y, Watanabe D, Akita Y, Matsumoto Y, Imai C, Kadono T, Maekawa T, Hattori N, Watanabe A, Torii H, Tamaki K: Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans. Clin Exp Dermatol; 2006 May;31(3):441-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In one case, the tumour was composed of two areas that differed in cytological atypia, cellularity and mitotic activity, indicating the dedifferentiation of the tumour.
  • These results suggest that the dedifferentiation of tumour cells has nothing to do with the specific breakpoints of the COL1A1 gene, but depends on other unknown factors.

  • Genetic Alliance. consumer health - Dermatofibrosarcoma Protuberans.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16681596.001).
  • [ISSN] 0307-6938
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Collagen Type I; 0 / Oncogene Proteins, Fusion; 0 / collagen type I, alpha 1 chain
  •  go-up   go-down


68. van Staveren WC, Solís DW, Delys L, Duprez L, Andry G, Franc B, Thomas G, Libert F, Dumont JE, Detours V, Maenhaut C: Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype. Cancer Res; 2007 Sep 1;67(17):8113-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype.
  • To investigate whether thyroid tumor-derived cell lines are representative in vitro models, characteristics of eight of those cell lines were investigated with microarrays, differentiation markers, and karyotyping.
  • Our results indicate that these cell lines derived from differentiated and undifferentiated tumor types have evolved in vitro into similar phenotypes with gene expression profiles the closest to in vivo undifferentiated tumors.
  • Accordingly, the absence of expression of most thyrocyte-specific genes, the nonresponsiveness to thyrotropin, as well as their large number of chromosomal abnormalities, suggest that these cell lines have acquired characteristics of fully dedifferentiated cells.
  • They represent the outcome of an adaptation and evolution in vitro, which questions the reliability of these cell lines as models for differentiated tumors.
  • However, they may represent useful models for undifferentiated cancers, and by their comparison with differentiated cells, can help to define the genes involved in the differentiation/dedifferentiation process.
  • [MeSH-major] Adenoma / pathology. Carcinoma, Papillary / pathology. Cell Differentiation. Cell Line, Tumor. Thyroid Neoplasms / pathology


69. Barciszewski J, Massino F, Clark BF: Kinetin--a multiactive molecule. Int J Biol Macromol; 2007 Feb 20;40(3):182-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Kinetin which was isolated 50 years ago for the first time as a plant hormone, as well as other cytokinins isopentenyladenine, zeatin and benzylaminopurine induce callus (clusters of dedifferentiated plant cells) to redifferentiate into adventitious buds.
  • Because of some similarities in the biological phenotypes of cancer and callus cells, cytokinins and especially kinetin, affect the differentiation of human cells through a common signal transduction system.
  • [MeSH-major] Cell Differentiation. Kinetin / metabolism. Plant Growth Regulators / metabolism. Signal Transduction. Tobacco / metabolism

  • Hazardous Substances Data Bank. ZEATIN .
  • Hazardous Substances Data Bank. KINETIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16899291.001).
  • [ISSN] 0141-8130
  • [Journal-full-title] International journal of biological macromolecules
  • [ISO-abbreviation] Int. J. Biol. Macromol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Plant Growth Regulators; 7I6OOJ9GR6 / Zeatin; P39Y9652YJ / Kinetin
  • [Number-of-references] 118
  •  go-up   go-down


70. Munirah S, Samsudin OC, Aminuddin BS, Ruszymah BH: Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy. Tissue Cell; 2010 Oct;42(5):282-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It has been well-documented that cell expansion is however accompanied by cellular dedifferentiation.
  • In order to promote cell growth and circumvent cellular dedifferentiation, we evaluated the effects of Transforming Growth Factor Beta-2 (TGF-β2), Insulin-like Growth Factor-I (IGF-I) and basic Fibroblast Growth Factor (bFGF) combination on articular chondrocytes culture and 'chondrocytes-fibrin' construct formation.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20810142.001).
  • [ISSN] 1532-3072
  • [Journal-full-title] Tissue & cell
  • [ISO-abbreviation] Tissue Cell
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Aggrecans; 0 / Collagen Type II; 0 / Culture Media; 0 / RNA, Messenger; 0 / SOX9 Transcription Factor; 0 / SOX9 protein, human; 0 / Transforming Growth Factor beta2; 103107-01-3 / Fibroblast Growth Factor 2; 67763-96-6 / Insulin-Like Growth Factor I; 9001-31-4 / Fibrin
  •  go-up   go-down


71. Boutet A, Esteban MA, Maxwell PH, Nieto MA: Reactivation of Snail genes in renal fibrosis and carcinomas: a process of reversed embryogenesis? Cell Cycle; 2007 Mar 15;6(6):638-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we show that in dedifferentiated areas of human renal carcinomas, Snail undergoes a process of reactivation.

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17374993.001).
  • [ISSN] 1551-4005
  • [Journal-full-title] Cell cycle (Georgetown, Tex.)
  • [ISO-abbreviation] Cell Cycle
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Transcription Factors; 0 / snail family transcription factors
  • [Number-of-references] 42
  •  go-up   go-down


72. Halloran PF: T cell-mediated rejection of kidney transplants: a personal viewpoint. Am J Transplant; 2010 May;10(5):1126-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Local inflammation triggers dedifferentiation of the adjacent epithelium (e.g. loss of transporters and expression of embryonic genes) rather than cell death, via mechanisms that do not require known T-cell cytotoxic mechanisms or direct contact of T cells with the epithelium.
  • Local epithelial changes trigger a response of the entire nephron and a second wave of dedifferentiation.
  • The dedifferentiated epithelium is unable to exclude T cells, which enter to produce tubulitis lesions.
  • Thus TCMR is a cognate recognition-based process that creates local inflammation and epithelial dedifferentiation, stereotyped nephron responses, and tubulitis, and if untreated causes irreversible nephron loss.

  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20346061.001).
  • [ISSN] 1600-6143
  • [Journal-full-title] American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • [ISO-abbreviation] Am. J. Transplant.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 58
  •  go-up   go-down


73. Tirabosco R, De Maglio G, Skrap M, Falconieri G, Pizzolitto S: Expression of the Polycomb-Group protein BMI1 and correlation with p16 in astrocytomas an immunohistochemical study on 80 cases. Pathol Res Pract; 2008;204(9):625-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BMI1, the prototype PcG gene, is critically involved in cell cycle control and differentiation, and despite the regulatory role demonstrated in central nervous system (CNS) development, its implication in brain tumorigenesis is scarcely known.
  • However, when the 22 BMI1 + /p16+ tumors were examined cytologically, a substantial proportion contained a significant gemistocytic component, which is thought to be an adverse prognostic factor or to display a high degree of anaplasia, suggesting a common molecular mechanism of BMI1/p16 pathway disruption, which may have prognostic implications.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18450386.001).
  • [ISSN] 0344-0338
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / BMI1 protein, human; 0 / Biomarkers, Tumor; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / Nuclear Proteins; 0 / Proto-Oncogene Proteins; 0 / Repressor Proteins; EC 6.3.2.19 / Polycomb Repressive Complex 1
  •  go-up   go-down


74. D'Agati VD: The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens; 2008 May;17(3):271-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE OF REVIEW: Focal segmental glomerulosclerosis (FSGS) is a disease with diverse histologic patterns and etiologic associations.
  • In the collapsing variant, podocyte dysregulation leads to podocyte dedifferentiation and glomerular epithelial cell proliferation.
  • [MeSH-major] Cell Dedifferentiation. Cell Proliferation. Glomerulosclerosis, Focal Segmental / etiology. Podocytes / pathology

  • Genetic Alliance. consumer health - Focal Segmental Glomerulosclerosis.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18408478.001).
  • [ISSN] 1062-4821
  • [Journal-full-title] Current opinion in nephrology and hypertension
  • [ISO-abbreviation] Curr. Opin. Nephrol. Hypertens.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 103
  •  go-up   go-down


75. Decker L, Desmarquet-Trin-Dinh C, Taillebourg E, Ghislain J, Vallat JM, Charnay P: Peripheral myelin maintenance is a dynamic process requiring constant Krox20 expression. J Neurosci; 2006 Sep 20;26(38):9771-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Onset of myelination in Schwann cells is governed by several transcription factors, including Krox20/Egr2, and mutations affecting Krox20 result in various human hereditary peripheral neuropathies, including congenital hypomyelinating neuropathy (CHN) and Charcot-Marie-Tooth disease (CMT).
  • In the latter case, specific inactivation of Krox20 in adult Schwann cells results in severe demyelination, involving rapid Schwann cell dedifferentiation and increased proliferation, followed by an attempt to remyelinate and a block at the promyelinating stage.


76. Cabibi D, Cipolla C, Maria Florena A, Fricano S, Barresi E, Vieni S, Rodolico V, Napoli L: Solid variant of mammary "adenoid cystic carcinoma with basaloid features" merging with "small cell carcinoma". Pathol Res Pract; 2005;201(10):705-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Furthermore, positivity for CD10 was found both in sbACC and in SCC, supporting the hypothesis that the two components share the same histogenetic myoepithelial origin and represent an example of dedifferentiation along neuroendocrine phenotype lines occurring in a multipotential neoplastic stem line, already committed towards a myoepithelial phenotype.

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16325513.001).
  • [ISSN] 0344-0338
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


77. Uenotsuchi T, Imafuku S, Moroi Y, Urabe K, Furue M: Large subcutaneous liposarcoma arising from the chest wall. Eur J Dermatol; 2005 Jan-Feb;15(1):43-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We eventually diagnosed the tumor as a well-differentiated liposarcoma, adipocytic type (lipoma-like type).
  • Patients with cutaneous and subcutaneous liposarcoma have a good prognosis, but there are reports of local recurrence after a long period, as well as high-grade change and dedifferentiation.

  • Genetic Alliance. consumer health - Liposarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15701593.001).
  • [ISSN] 1167-1122
  • [Journal-full-title] European journal of dermatology : EJD
  • [ISO-abbreviation] Eur J Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


78. Mohan J, Bruce ME, Mabbott NA: Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin. Immunology; 2005 Feb;114(2):225-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin.
  • Temporary dedifferentiation of follicular dendritic cells (FDCs) by treatment with an inhibitor of the lymphotoxin-beta receptor signalling pathway (LTbetaR-Ig) 3 days before or 14 days after inoculation via the skin, blocked the early accumulation of PrP(Sc) and TSE infectivity within the draining lymph node.
  • Furthermore, in the temporary absence of FDCs before inoculation, disease susceptibility was reduced and survival time significantly extended.
  • Treatment with LTbetaR-Ig 14 days after TSE inoculation also significantly extended the disease incubation period.
  • However, treatment 42 days after inoculation did not affect disease susceptibility or survival time, suggesting that the infection may have already have spread to the nervous system.
  • [MeSH-minor] Animals. Disease Susceptibility. Immunoblotting / methods. Immunoglobulin Fc Fragments / administration & dosage. Immunoglobulin G / administration & dosage. Injections. Lymph Nodes / chemistry. Lymphotoxin beta Receptor. Mice. Mice, Inbred BALB C. PrPSc Proteins / analysis. Receptors, Tumor Necrosis Factor / administration & dosage. Spleen / chemistry

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2001 Sep;108(5):703-8 [11544275.001]
  • [Cites] Mol Med. 2001 Oct;7(10):679-84 [11713367.001]
  • [Cites] J Am Acad Dermatol. 2002 May;46(5):790-3 [12004327.001]
  • [Cites] Eur J Immunol. 2002 Jul;32(7):1888-96 [12115608.001]
  • [Cites] Semin Immunol. 2002 Aug;14(4):285-93 [12163304.001]
  • [Cites] J Virol. 2003 Jan;77(1):583-91 [12477862.001]
  • [Cites] J Virol. 2003 Jun;77(12):6845-54 [12768004.001]
  • [Cites] J Clin Invest. 2003 Sep;112(5):755-67 [12952924.001]
  • [Cites] Nature. 2003 Oct 30;425(6961):957-62 [14562059.001]
  • [Cites] Lancet. 2004 Feb 7;363(9407):417-21 [14962520.001]
  • [Cites] J Dermatol Sci. 2004 Aug;35(2):101-11 [15265522.001]
  • [Cites] Lancet. 2004 Aug 7-13;364(9433):527-9 [15302196.001]
  • [Cites] J Comp Pathol. 1968 Jan;78(1):9-17 [4967999.001]
  • [Cites] J Comp Pathol. 1969 Jan;79(1):15-22 [4975615.001]
  • [Cites] Nature. 1970 May 2;226(5244):462-3 [4985820.001]
  • [Cites] Nature. 1971 Oct 1;233(5318):336 [4940428.001]
  • [Cites] J Comp Pathol. 1973 Jan;83(1):29-40 [4199908.001]
  • [Cites] N Engl J Med. 1974 Mar 21;290(12):692-3 [4591849.001]
  • [Cites] J Comp Pathol. 1978 Oct;88(4):563-73 [101558.001]
  • [Cites] Intervirology. 1981;16(1):8-13 [6799420.001]
  • [Cites] Intervirology. 1982;17(4):201-7 [6813286.001]
  • [Cites] Science. 1982 Dec 24;218(4579):1309-11 [6815801.001]
  • [Cites] Biochemistry. 1982 Dec 21;21(26):6942-50 [6818988.001]
  • [Cites] J Virol Methods. 1989 Apr-May;24(1-2):215-21 [2569471.001]
  • [Cites] J Pathol. 1992 Dec;168(4):413-8 [1362440.001]
  • [Cites] J Immunol. 1993 Apr 1;150(7):2648-58 [8454847.001]
  • [Cites] Immunology. 1993 Sep;80(1):34-9 [8244461.001]
  • [Cites] J Gen Virol. 1994 Mar;75 ( Pt 3):495-504 [7907357.001]
  • [Cites] J Immunol. 1995 Dec 1;155(11):5280-8 [7594541.001]
  • [Cites] J Clin Microbiol. 1996 May;34(5):1228-31 [8727908.001]
  • [Cites] Nature. 1996 Aug 1;382(6590):462-6 [8684487.001]
  • [Cites] J Gen Virol. 1996 Jul;77 ( Pt 7):1595-9 [8758004.001]
  • [Cites] Immunity. 1997 Apr;6(4):491-500 [9133428.001]
  • [Cites] Immunol Today. 1997 May;18(5):225-30 [9153954.001]
  • [Cites] Nature. 1997 Dec 18-25;390(6661):687-90 [9414161.001]
  • [Cites] Immunity. 1998 Jan;8(1):21-30 [9462508.001]
  • [Cites] Curr Opin Immunol. 1998 Jun;10(3):289-97 [9638365.001]
  • [Cites] Nat Med. 1999 Nov;5(11):1308-12 [10545999.001]
  • [Cites] J Gen Virol. 1999 Oct;80 ( Pt 10):2757-64 [10573172.001]
  • [Cites] Am J Pathol. 2000 Jan;156(1):51-6 [10623653.001]
  • [Cites] J Pathol. 2000 Mar;190(4):495-502 [10700001.001]
  • [Cites] J Virol. 2000 Apr;74(7):3338-44 [10708451.001]
  • [Cites] Immunology. 2000 May;100(1):4-12 [10809953.001]
  • [Cites] Science. 2000 May 19;288(5469):1257-9 [10818004.001]
  • [Cites] Annu Rev Immunol. 2000;18:767-811 [10837075.001]
  • [Cites] Nat Med. 2000 Jul;6(7):719-20 [10888894.001]
  • [Cites] Nature. 2000 Nov 2;408(6808):3-4 [11081474.001]
  • [Cites] Nat Med. 2001 Apr;7(4):485-7 [11283677.001]
  • [Cites] Nat Med. 2001 Apr;7(4):488-92 [11283678.001]
  • [Cites] J Exp Med. 2001 Jun 4;193(11):1227-38 [11390430.001]
  • [Cites] Neuron. 2001 Jul 19;31(1):25-34 [11498048.001]
  • [Cites] Immunity. 1998 Jul;9(1):59-70 [9697836.001]
  • [Cites] Nature. 1998 Sep 3;395(6697):26-7 [9738494.001]
  • [Cites] Nat Med. 1998 Dec;4(12):1429-33 [9846583.001]
  • [Cites] J Exp Med. 1999 Jan 4;189(1):159-68 [9874572.001]
  • [Cites] Lancet. 1999 Jan 16;353(9148):183-9 [9923873.001]
  • [Cites] J Exp Med. 1999 Sep 6;190(5):629-38 [10477548.001]
  • (PMID = 15667567.001).
  • [ISSN] 0019-2805
  • [Journal-full-title] Immunology
  • [ISO-abbreviation] Immunology
  • [Language] eng
  • [Grant] United Kingdom / Biotechnology and Biological Sciences Research Council / / BBS/E/I/00000989
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Immunoglobulin Fc Fragments; 0 / Immunoglobulin G; 0 / Ltbr protein, mouse; 0 / Lymphotoxin beta Receptor; 0 / PrPSc Proteins; 0 / Receptors, Tumor Necrosis Factor
  • [Other-IDs] NLM/ PMC1782078
  •  go-up   go-down


79. Wootton SK, Metzger MJ, Hudkins KL, Alpers CE, York D, DeMartini JC, Miller AD: Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV. Retrovirology; 2006 Dec 19;3:94
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, the mouse and sheep tumors have not been carefully compared to determine if Env expression alone in mice can account for the disease features observed in sheep, or whether additional aspects of virus replication in sheep are important, such as oncogene activation following retrovirus integration into the host cell genome.
  • Mouse and sheep tumors consisted mainly of well-differentiated adenomatous foci with little histological evidence of anaplasia, but at long times after vector exposure some mouse tumors did have a more malignant appearance typical of adenocarcinoma.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Top Microbiol Immunol. 2003;275:25-54 [12596894.001]
  • [Cites] J Gen Virol. 2002 Nov;83(Pt 11):2733-42 [12388809.001]
  • [Cites] Curr Top Microbiol Immunol. 2003;275:117-37 [12596897.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4580-5 [12676986.001]
  • [Cites] J Virol. 2003 Jul;77(14):7924-35 [12829832.001]
  • [Cites] Virology. 2003 Jul 20;312(1):95-105 [12890624.001]
  • [Cites] J Biol Chem. 2004 Jan 9;279(2):1050-9 [14593117.001]
  • [Cites] J Virol. 2004 Aug;78(16):8506-12 [15280459.001]
  • [Cites] J Am Vet Med Assoc. 1967 Sep 15;151(6):732-4 [6069985.001]
  • [Cites] Science. 1983 Mar 11;219(4589):1228-30 [6402815.001]
  • [Cites] Am J Vet Res. 1982 Dec;43(12):2108-13 [7165156.001]
  • [Cites] Arch Virol. 1983;78(1-2):89-95 [6197047.001]
  • [Cites] Cornell Vet. 1985 Apr;75(2):269-76 [3987295.001]
  • [Cites] Cancer Res. 1990 Aug 1;50(15):4787-93 [2164448.001]
  • [Cites] J Virol. 1992 Aug;66(8):4930-9 [1629959.001]
  • [Cites] J Gen Virol. 1995 Nov;76 ( Pt 11):2731-7 [7595380.001]
  • [Cites] J Gen Virol. 1996 Dec;77 ( Pt 12):2991-8 [9000089.001]
  • [Cites] Science. 1997 Jun 20;276(5320):1848-50 [9188528.001]
  • [Cites] J Virol. 1999 May;73(5):4004-8 [10196296.001]
  • [Cites] Virology. 1999 Jun 5;258(2):333-43 [10366570.001]
  • [Cites] J Virol. 1999 Aug;73(8):6964-72 [10400795.001]
  • [Cites] Cornell Vet. 1961 Jan;51:96-112 [13787496.001]
  • [Cites] Vet Rec. 2004 Oct 23;155(17):526-8 [15551928.001]
  • [Cites] J Virol. 2005 Jan;79(2):927-33 [15613321.001]
  • [Cites] Nature. 2005 Apr 14;434(7035):904-7 [15829964.001]
  • [Cites] Virology. 2005 Jul 20;338(1):144-53 [15950254.001]
  • [Cites] Retrovirology. 2005;2:59 [16191204.001]
  • [Cites] Virus Res. 2006 May;117(2):254-63 [16310879.001]
  • [Cites] J Virol. 2006 Aug;80(16):8030-7 [16873259.001]
  • [Cites] J Virol. 2006 Sep;80(18):9322-5 [16940543.001]
  • [Cites] J Virol. 2003 Mar;77(5):2850-8 [12584308.001]
  • [Cites] Am J Pathol. 2000 Jan;156(1):175-82 [10623665.001]
  • [Cites] J Comp Pathol. 2000 Jan;122(1):55-65 [10627391.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1749-53 [10677529.001]
  • [Cites] J Virol. 2000 May;74(10):4698-704 [10775607.001]
  • [Cites] Mol Ther. 2000 Jan;1(1):88-95 [10933916.001]
  • [Cites] Virology. 2000 Oct 10;276(1):161-8 [11022004.001]
  • [Cites] J Virol. 2001 May;75(9):4239-46 [11287573.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4443-8 [11296287.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4449-54 [11296288.001]
  • [Cites] J Virol. 2001 Jul;75(14):6615-24 [11413329.001]
  • [Cites] J Virol. 2001 Nov;75(22):11002-9 [11602740.001]
  • [Cites] Oncogene. 2002 Feb 28;21(10):1518-26 [11896580.001]
  • [Cites] Vet Pathol. 2002 May;39(3):341-52 [12014498.001]
  • [Cites] Curr Top Microbiol Immunol. 2003;275:55-79 [12596895.001]
  • (PMID = 17177996.001).
  • [ISSN] 1742-4690
  • [Journal-full-title] Retrovirology
  • [ISO-abbreviation] Retrovirology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / T32 CA009229; United States / NCI NIH HHS / CA / CA09229
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Gene Products, env
  • [Other-IDs] NLM/ PMC1764900
  •  go-up   go-down


80. Gosset M, Berenbaum F, Thirion S, Jacques C: Primary culture and phenotyping of murine chondrocytes. Nat Protoc; 2008;3(8):1253-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The culture of chondrocytes is one of the most powerful tools for exploring the intracellular and molecular features of chondrocyte differentiation and activation.
  • However, chondrocytes tend to dedifferentiate into fibroblasts when they are subcultured, which is a major problem.
  • This protocol, involving primary cultures to limit dedifferentiation, describes two different methods for culturing chondrocytes of different anatomical origins (articular and costal chondrocytes, both of which represent hyaline cartilage) from mice.
  • [MeSH-minor] Animals. Cartilage / cytology. Cell Differentiation. Culture Media. Mice

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18714293.001).
  • [ISSN] 1750-2799
  • [Journal-full-title] Nature protocols
  • [ISO-abbreviation] Nat Protoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Culture Media
  •  go-up   go-down


81. Korzhevskiĭ DE, Lentsman MV, Giliarov AV, Kostkin VB, Otellin VA: [Morphological manifestations of astrocyte local functional activation produced by a short-term total brain ischemia]. Zh Evol Biokhim Fiziol; 2007 Sep-Oct;43(5):423-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The obtained data allow suggesting that the postischemic activation of astrocytes is accompanied by their acquistition of properties characteristic of immature cells of the nervous tissue; however, the absence of morphological signs of dedifferentiation does not permit these cells to be considered responsible for reparational neurogenesis in hippocampus.
  • [MeSH-minor] Animals. Cell Size. Disease Models, Animal. Immunohistochemistry. Male. Nestin. Rats. Rats, Sprague-Dawley

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18038640.001).
  • [ISSN] 0044-4529
  • [Journal-full-title] Zhurnal evoliutsionnoĭ biokhimii i fiziologii
  • [ISO-abbreviation] Zh. Evol. Biokhim. Fiziol.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Glial Fibrillary Acidic Protein; 0 / Intermediate Filament Proteins; 0 / Nerve Tissue Proteins; 0 / Nes protein, rat; 0 / Nestin
  •  go-up   go-down


82. Zwickl H, Niculescu-Morzsa E, Nehrer S: Investigation of Collagen Transplants Seeded with Human Autologous Chondrocytes at the Time of Transplantation. Cartilage; 2010 Jul;1(3):194-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, chondrocytes showed collagen I mRNA expression partially far exceeding that of collagen II, indicating a rather dedifferentiated cellular status.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 26069551.001).
  • [ISSN] 1947-6035
  • [Journal-full-title] Cartilage
  • [ISO-abbreviation] Cartilage
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC4297067
  • [Keywords] NOTNLM ; articular cartilage / biomaterials / chondrocytes / repair / tissue engineering
  •  go-up   go-down


83. Sade S, Al Habeeb A, Ghazarian D: Spindle cell melanocytic lesions--part I: an approach to compound naevoidal pattern lesions with spindle cell morphology and Spitzoid pattern lesions. J Clin Pathol; 2010 Apr;63(4):296-321
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The presence of spindle cells may mask the melanocytic nature of a lesion, and is often disconcerting, either because of its infrequent appearance in a particular lesion or its interpretation as a dedifferentiated phenotype.
  • Spindle cell melanocytic lesions follow the full spectrum of potential biological outcomes, and difficulty may be experienced judging the nature of a lesion because of a lack of consistently reliable features to predict biological behaviour.
  • Over time, recognition of numerous histomorphological features that may portend a more aggressive lesion have been identified.
  • [MeSH-minor] Aged. Algorithms. Cell Differentiation. Child, Preschool. Diagnosis, Differential. Female. Humans. Infant. Infant, Newborn. Male. Melanocytes / pathology. Melanoma / pathology. Middle Aged. Nevus, Pigmented / congenital. Nevus, Pigmented / pathology. Nevus, Spindle Cell / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20354202.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 122
  •  go-up   go-down


84. Eisner BH, McAleer SJ, Gargollo PC, Perez-Atayde A, Diamond DA, Elder JS: Pediatric penile tumors of mesenchymal origin. Urology; 2006 Dec;68(6):1327-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Immunohistochemical staining showed strong and diffuse CD34 cytoplasmic positivity in the giant cell fibroblastoma and dermatofibrosarcoma protuberans components; the dedifferentiated fibrosarcoma tumor cells were negative for this antibody.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17169655.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. Morikawa S, Mabuchi Y, Niibe K, Suzuki S, Nagoshi N, Sunabori T, Shimmura S, Nagai Y, Nakagawa T, Okano H, Matsuzaki Y: Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun; 2009 Feb 20;379(4):1114-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Previous studies reported that MSCs can differentiate to both mesodermal and neural lineages by a phenomenon referred to as ''dedifferentiation'' or ''transdifferentiation''.
  • EGFP-positive MSCs formed spheres that expressed neural crest stem cell genes and differentiated into neurons, glial cells, and myofibroblasts.
  • [MeSH-minor] Animals. Antigens, CD45 / analysis. Ataxin-1. Ataxins. Blood Group Antigens / analysis. Cell Differentiation. Clone Cells. Green Fluorescent Proteins / genetics. Mice. Mice, Transgenic. Nerve Tissue Proteins / analysis. Nuclear Proteins / analysis. Receptor, Platelet-Derived Growth Factor alpha / analysis

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19161980.001).
  • [ISSN] 1090-2104
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ataxin-1; 0 / Ataxins; 0 / Atxn1 protein, mouse; 0 / Blood Group Antigens; 0 / Nerve Tissue Proteins; 0 / Nuclear Proteins; 0 / TER-119 antigen, mouse; 0 / enhanced green fluorescent protein; 147336-22-9 / Green Fluorescent Proteins; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor alpha; EC 3.1.3.48 / Antigens, CD45
  •  go-up   go-down


86. Nucera C, Nehs MA, Mekel M, Zhang X, Hodin R, Lawler J, Nose V, Parangi S: A novel orthotopic mouse model of human anaplastic thyroid carcinoma. Thyroid; 2009 Oct;19(10):1077-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel orthotopic mouse model of human anaplastic thyroid carcinoma.
  • METHODS: We used the cell line 8505c, originated from a thyroid tumor histologically characterized by anaplastic carcinoma cell features.
  • RESULTS: Orthotopic implantation with the 8505c cells produced thyroid tumors after 5 weeks, showing large neck masses, with histopathologic features of a high-grade neoplasm (anaplasia, necrosis, high mitotic and proliferative indexes, p53 positivity, extrathyroidal invasion, lymph node and distant metastases) and immunoprofile of follicular thyroid cell origin with positivity for thyroid transcription factor-1 and PAX8, and for cytokeratins.
  • [MeSH-minor] Animals. Cell Line, Tumor. Cell Proliferation. Disease Models, Animal. Genes, p53 / genetics. Humans. Immunohistochemistry. Mice. Neoplasm Transplantation. Proto-Oncogene Proteins B-raf / genetics. Thyroid Gland / cytology. Thyroid Gland / pathology. Transfection

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anticancer Res. 2001 Mar-Apr;21(2A):1035-42 [11396137.001]
  • [Cites] Am J Pathol. 2002 Nov;161(5):1549-56 [12414503.001]
  • [Cites] Eur J Cancer. 2004 Apr;40(6):852-7 [15120041.001]
  • [Cites] Oncogene. 2004 Aug 12;23(36):6031-9 [15208655.001]
  • [Cites] Mod Pathol. 2004 Nov;17(11):1359-63 [15195111.001]
  • [Cites] Cancer Metastasis Rev. 1991 Oct;10(3):201-15 [1764765.001]
  • [Cites] Cancer Res. 1992 Sep 15;52(18):5061-4 [1516062.001]
  • [Cites] Anticancer Res. 1993 May-Jun;13(3):627-30 [8391244.001]
  • [Cites] Cancer Res. 1994 Sep 1;54(17):4744-9 [8062273.001]
  • [Cites] J Cell Biochem. 1994 Sep;56(1):4-8 [7806591.001]
  • [Cites] Oncogene. 1996 Apr 18;12(8):1821-6 [8622903.001]
  • [Cites] Am J Pathol. 1997 Sep;151(3):679-88 [9284816.001]
  • [Cites] Semin Surg Oncol. 1999 Jan-Feb;16(1):64-9 [9890741.001]
  • [Cites] Cancer Metastasis Rev. 1998-1999;17(3):279-84 [10352881.001]
  • [Cites] Endocrinology. 2004 Dec;145(12):5840-6 [15319350.001]
  • [Cites] Clin Cancer Res. 2005 Mar 1;11(5):1713-21 [15755992.001]
  • [Cites] Cancer Res. 2005 May 15;65(10):4238-45 [15899815.001]
  • [Cites] Clin Cancer Res. 2006 Jan 15;12(2):600-7 [16428506.001]
  • [Cites] J Natl Cancer Inst. 2006 Mar 1;98(5):326-34 [16507829.001]
  • [Cites] Head Neck. 2006 May;28(5):389-99 [16388530.001]
  • [Cites] Pathol Int. 2006 May;56(5):240-5 [16669872.001]
  • [Cites] Thyroid. 2006 Feb;16(2):109-42 [16420177.001]
  • [Cites] Cancer Control. 2006 Apr;13(2):119-28 [16735986.001]
  • [Cites] Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3425-34 [16740767.001]
  • [Cites] Clin Cancer Res. 2006 Aug 1;12(15):4755-65 [16899627.001]
  • [Cites] Mol Cancer Ther. 2006 Oct;5(10):2435-43 [17041086.001]
  • [Cites] Vet Pathol. 2007 Jan;44(1):1-14 [17197619.001]
  • [Cites] Laryngoscope. 2007 Apr;117(4):674-9 [17429874.001]
  • [Cites] Mol Cancer Ther. 2007 Apr;6(4):1329-37 [17431111.001]
  • [Cites] Mol Cancer Ther. 2007 Jun;6(6):1785-92 [17575107.001]
  • [Cites] Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4519-27 [17671138.001]
  • [Cites] Thyroid. 2007 Aug;17(8):707-15 [17725429.001]
  • [Cites] Cancer Res. 2007 Dec 15;67(24):11821-9 [18089812.001]
  • [Cites] Mod Pathol. 2008 Feb;21(2):192-200 [18084247.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2008 Feb;134(2):190-7 [18283163.001]
  • [Cites] Cancer Res. 2008 Oct 1;68(19):8104-12 [18829569.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41 [18713817.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Mar;89(3):1365-8 [15001635.001]
  • (PMID = 19772429.001).
  • [ISSN] 1557-9077
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA149738
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.11.1 / Proto-Oncogene Proteins B-raf
  • [Other-IDs] NLM/ PMC2833178
  •  go-up   go-down


87. Kogure T, Ueno Y, Sekiguchi S, Ishida K, Igarashi T, Wakui Y, Iwasaki T, Shimosegawa T: Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma. World J Gastroenterol; 2009 Mar 14;15(10):1267-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma.
  • However, radiological findings altered, which caused us to suspect that a well-differentiated hepatocellular carcinoma (HCC) containing fat was becoming dedifferentiated.
  • This case was an extremely rare LCA, which had no background of risk for LCA and developed the sequential alteration of the radiological findings to suspect well-differentiated HCC.

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Liver Transpl Surg. 1995 Mar;1(2):99-102 [9346548.001]
  • [Cites] Hepatogastroenterology. 1998 Jan-Feb;45(19):224-5 [9496518.001]
  • [Cites] Am J Gastroenterol. 1982 Jul;77(7):504-8 [6283882.001]
  • [Cites] Gastroenterology. 1983 May;84(5 Pt 1):994-1002 [6299876.001]
  • [Cites] Ann Intern Med. 1984 Feb;100(2):316 [6691682.001]
  • [Cites] N Engl J Med. 1984 Apr 26;310(17):1120-1 [6323982.001]
  • [Cites] Surgery. 1985 Jan;97(1):117-24 [3855331.001]
  • [Cites] Gastroenterology. 1985 Nov;89(5):1132-8 [2412930.001]
  • [Cites] Ann Intern Med. 1986 Oct;105(4):547-9 [3019201.001]
  • [Cites] Ann Surg. 1988 Nov;208(5):558-64 [3190282.001]
  • [Cites] Am J Gastroenterol. 1989 Apr;84(4):429-32 [2929567.001]
  • [Cites] Surg Gynecol Obstet. 1991 Nov;173(5):426-31 [1658955.001]
  • [Cites] Histol Histopathol. 1989 Jul;4(3):301-3 [2562466.001]
  • [Cites] Hepatology. 1995 Dec;22(6):1674-81 [7489973.001]
  • [Cites] J Gastroenterol. 1996 Jun;31(3):441-5 [8726839.001]
  • [Cites] Abdom Imaging. 1997 May-Jun;22(3):274-6 [9107649.001]
  • [Cites] Eur J Contracept Reprod Health Care. 1998 Mar;3(1):7-16 [9678067.001]
  • [Cites] Liver Transpl Surg. 1998 Sep;4(5):388-98 [9724476.001]
  • [Cites] Dig Liver Dis. 2005 Mar;37(3):200-5 [15888286.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2006 Apr;18(4):437-41 [16538118.001]
  • [Cites] Liver Int. 2006 May;26(4):433-8 [16629646.001]
  • [Cites] Radiology. 2006 Nov;241(2):433-40 [16966481.001]
  • [Cites] Br J Surg. 2006 Dec;93(12):1495-502 [17051603.001]
  • [Cites] Ann Surg. 2000 Jan;231(1):74-81 [10636105.001]
  • [Cites] World J Surg. 2000 Mar;24(3):372-6 [10658075.001]
  • [Cites] Radiology. 2000 Aug;216(2):395-402 [10924560.001]
  • [Cites] J Gastroenterol. 2001 Jan;36(1):52-61 [11211213.001]
  • [Cites] Br J Surg. 2001 Jun;88(6):808-13 [11412249.001]
  • [Cites] Radiographics. 2001 Jul-Aug;21(4):877-92; discussion 892-4 [11452062.001]
  • [Cites] World J Gastroenterol. 2003 Oct;9(10):2379-81 [14562419.001]
  • [Cites] Lancet. 1973 Oct 27;2(7835):926-9 [4126557.001]
  • [Cites] Arch Surg. 1975 May;110(5):548-57 [1131000.001]
  • [Cites] N Engl J Med. 1976 Feb 26;294(9):470-2 [173996.001]
  • [Cites] Gastroenterology. 1981 Sep;81(3):534-6 [6941908.001]
  • (PMID = 19291830.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P50 CA095817
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2658857
  •  go-up   go-down


88. Déglise S, Martin D, Probst H, Saucy F, Hayoz D, Waeber G, Nicod P, Ris HB, Corpataux JM, Haefliger JA: Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia. J Vasc Surg; 2005 Jun;41(6):1043-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mechanisms involved in intimal hyperplasia are proliferation, dedifferentiation, and migration of medial smooth muscle cells towards the subintimal space.
  • We postulated that gap junctions, which coordinate physiologic processes such as cell growth and differentiation, might participate in the development of intimal hyperplasia.
  • In this model, the morphologic and functional integrity of the vessel wall is maintained and significant intimal hyperplasia development occurs after 14 days in culture.
  • We have postulated that gap junctions, which coordinate physiologic processes such as cell growth and differentiation, may participate in the development of intimal hyperplasia.
  • [MeSH-minor] Blotting, Western. Cell Differentiation. Cells, Cultured. Endothelial Cells / metabolism. Fatty Acids, Monounsaturated / pharmacology. Female. Humans. Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology. Hyperplasia. Indoles / pharmacology. Male. Middle Aged. Organ Culture Techniques. Reverse Transcriptase Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15944608.001).
  • [ISSN] 0741-5214
  • [Journal-full-title] Journal of vascular surgery
  • [ISO-abbreviation] J. Vasc. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Connexin 43; 0 / Fatty Acids, Monounsaturated; 0 / Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0 / Indoles; 4L066368AS / fluvastatin
  •  go-up   go-down


89. Thöm K, Bontikous S, Engelhardt M, Düring T, Schulte M: [Intracortical dedifferentiated chondrosarcoma]. Unfallchirurg; 2009 Jul;112(7):656-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracortical dedifferentiated chondrosarcoma].
  • During the staging examination of a 59-year-old patient referred to our clinic because of a squamous cell carcinoma of the oropharynx, we also found a highly malignant intracortical dedifferentiated chondrosarcoma of the distal femur shaft.

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1991 Nov;181(2):409-13 [1924781.001]
  • [Cites] Skeletal Radiol. 1990;19(1):59-61 [2326658.001]
  • [Cites] J Bone Joint Surg Am. 2003 Mar;85-A(3):533-5 [12637443.001]
  • [Cites] Clin Orthop Relat Res. 1992 Jun;(279):269-80 [1600666.001]
  • [Cites] Skeletal Radiol. 1996 Jul;25(5):455-9 [8837277.001]
  • [Cites] Unfallchirurg. 2002 Dec;105(12):1139-42 [12486582.001]
  • [Cites] Hum Pathol. 1998 May;29(5):438-46 [9596266.001]
  • [Cites] Skeletal Radiol. 1998 Oct;27(10 ):581-3 [9840397.001]
  • [Cites] J Bone Joint Surg Br. 1982;64(3):370-6 [7096408.001]
  • [Cites] J Bone Joint Surg Am. 1998 Nov;80(11):1673-8 [9840637.001]
  • [Cites] Cancer. 1980 Dec 1;46(11):2525-33 [7002283.001]
  • [Cites] Cancer. 1972 Sep;30(3):726-36 [5075357.001]
  • (PMID = 19543872.001).
  • [ISSN] 1433-044X
  • [Journal-full-title] Der Unfallchirurg
  • [ISO-abbreviation] Unfallchirurg
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


90. Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, Egli D, Maherali N, Park IH, Yu J, Daley GQ, Eggan K, Hochedlinger K, Thomson J, Wang W, Gao Y, Zhang K: Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol; 2009 Apr;27(4):353-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate epigenetic differences associated with dedifferentiation, we compared methylation in three human fibroblast lines and eight human pluripotent stem cell lines.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Genome Biol. 2003;4(5):P3 [12734009.001]
  • [Cites] Nat Biotechnol. 2003 Jun;21(6):673-8 [12730666.001]
  • [Cites] J Mol Biol. 1987 Jul 20;196(2):261-82 [3656447.001]
  • [Cites] Trends Genet. 1999 Jan;15(1):34-7 [10087932.001]
  • [Cites] PLoS Biol. 2004 Dec;2(12):e405 [15550986.001]
  • [Cites] Science. 2005 Aug 26;309(5739):1369-73 [16123299.001]
  • [Cites] Nucleic Acids Res. 2005;33(18):5868-77 [16224102.001]
  • [Cites] Genome Res. 2006 Mar;16(3):383-93 [16449502.001]
  • [Cites] Genome Res. 2006 Aug;16(8):1046-55 [16809668.001]
  • [Cites] Genome Res. 2006 Sep;16(9):1075-83 [16899657.001]
  • [Cites] Cell. 2006 Sep 22;126(6):1189-201 [16949657.001]
  • [Cites] Nat Genet. 2006 Dec;38(12):1378-85 [17072317.001]
  • [Cites] Science. 2007 Feb 23;315(5815):1141-3 [17322062.001]
  • [Cites] Cancer Res. 2007 Sep 15;67(18):8511-8 [17875690.001]
  • [Cites] Development. 2007 Nov;134(22):3959-65 [17928417.001]
  • [Cites] Nat Methods. 2007 Nov;4(11):931-6 [17934468.001]
  • [Cites] Science. 2007 Dec 21;318(5858):1917-20 [18029452.001]
  • [Cites] Nature. 2008 Jan 10;451(7175):141-6 [18157115.001]
  • [Cites] Nat Methods. 2008 Dec;5(12):1005-10 [19034268.001]
  • [Cites] Nat Genet. 2009 Feb;41(2):178-86 [19151715.001]
  • [Cites] Nat Biotechnol. 2009 Feb;27(2):182-9 [19182786.001]
  • [Cites] Nat Biotechnol. 2009 Apr;27(4):361-8 [19329998.001]
  • [Cites] Bioinformatics. 2008 Mar 1;24(5):713-4 [18227114.001]
  • [Cites] Nature. 2008 Mar 13;452(7184):215-9 [18278030.001]
  • [Cites] Genome Res. 2008 May;18(5):780-90 [18316654.001]
  • [Cites] Cell. 2008 May 2;133(3):523-36 [18423832.001]
  • [Cites] Nat Rev Genet. 2008 Jun;9(6):465-76 [18463664.001]
  • [Cites] Nature. 2008 Jul 3;454(7200):49-55 [18509334.001]
  • [Cites] Nature. 2008 Aug 7;454(7205):766-70 [18600261.001]
  • [Cites] Cell Stem Cell. 2008 Sep 11;3(3):340-5 [18786420.001]
  • [Cites] Nature. 2008 Sep 18;455(7211):401-5 [18724358.001]
  • [CommentIn] Nat Biotechnol. 2009 Apr;27(4):341-2 [19352369.001]
  • (PMID = 19330000.001).
  • [ISSN] 1546-1696
  • [Journal-full-title] Nature biotechnology
  • [ISO-abbreviation] Nat. Biotechnol.
  • [Language] ENG
  • [Databank-accession-numbers] GEO/ GSE15007
  • [Grant] United States / NIDA NIH HHS / DA / DA025779-01; United States / NIDA NIH HHS / DA / R01 DA025779; United States / NIDA NIH HHS / DA / R01 DA025779-01; United States / NIDA NIH HHS / DA / R01-DA025779
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Sulfites; 9007-49-2 / DNA; OJ9787WBLU / hydrogen sulfite
  • [Other-IDs] NLM/ NIHMS124917; NLM/ PMC2715272
  •  go-up   go-down


91. Deloin X, Dumaine V, Biau D, Karoubi M, Babinet A, Tomeno B, Anract P: Pelvic chondrosarcomas: surgical treatment options. Orthop Traumatol Surg Res; 2009 Oct;95(6):393-401
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Chondrosarcoma (CS) is a primary malignant bone tumor with cartilaginous differentiation.
  • Eleven patients had a grade 1 chondrosarcoma, 36 a grade 2 chondrosarcoma, five were grade 3, and seven were dedifferentiated chondrosarcoma.
  • Twenty-three patients (39%) died from the disease.
  • [MeSH-minor] Adult. Aged. Disease-Free Survival. Female. Follow-Up Studies. Humans. Kaplan-Meier Estimate. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Recurrence, Local. Proportional Hazards Models. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2009 Elsevier Masson SAS. All rights reserved.
  • (PMID = 19801212.001).
  • [ISSN] 1877-0568
  • [Journal-full-title] Orthopaedics & traumatology, surgery & research : OTSR
  • [ISO-abbreviation] Orthop Traumatol Surg Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  • [General-notes] NLM/ Original DateCompleted: 20100201
  •  go-up   go-down


92. Heebøll S, Borre M, Ottosen PD, Andersen CL, Mansilla F, Dyrskjøt L, Orntoft TF, Tørring N: SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation. Histol Histopathol; 2008 09;23(9):1069-76
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation.
  • In contrast, 20% of the specimens from patients with non-metastatic and non-recurrent disease showed moderate to marked staining.
  • In 31% of the patients with recurrent disease and in 31% of the patients with metastatic disease we found moderate to strong SMARCC1 immunostaining.
  • In a logistic regression analysis, patients with a marked SMARCC1 immunostaining had a significantly elevated odds ratio (OR) of 16 for recurrent cancer and an OR of 4.5 for metastatic disease.
  • Conclusions. Our present results demonstrate an increased expression of SMARCC1 protein in prostate cancer and reveal a positive correlation with tumour dedifferentiation, progression, metastasis and time to recurrence.
  • [MeSH-minor] Animals. Biomarkers, Tumor / metabolism. COS Cells. Cell Dedifferentiation. Cell Nucleus / metabolism. Cell Nucleus / pathology. Cercopithecus aethiops. Fluorescent Antibody Technique, Direct. Humans. Immunoenzyme Techniques. Lymph Nodes / metabolism. Lymph Nodes / pathology. Lymphatic Metastasis. Male. Neoplasm Recurrence, Local. Odds Ratio. Prostate / metabolism. Prostate / pathology. Prostatic Hyperplasia / metabolism. Prostatic Hyperplasia / pathology. Tissue Array Analysis. Up-Regulation

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18581278.001).
  • [ISSN] 1699-5848
  • [Journal-full-title] Histology and histopathology
  • [ISO-abbreviation] Histol. Histopathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / SMARCC1 protein, human; 0 / Transcription Factors
  •  go-up   go-down


93. Seethala RR: An update on grading of salivary gland carcinomas. Head Neck Pathol; 2009 Mar;3(1):69-77
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mucoepidermoid carcinomas are graded in a three tier fashion based on a constellation of features including cystic component, border, mitoses, anaplasia, and perineural invasion among others.

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2007 Nov;31(11):1683-94 [18059225.001]
  • [Cites] Otolaryngol Head Neck Surg. 2005 Nov;133(5):702-8 [16274796.001]
  • [Cites] Cancer. 2008 Oct 15;113(8):2082-9 [18720358.001]
  • [Cites] Am J Surg Pathol. 2009 Mar;33(3):409-16 [18971778.001]
  • [Cites] Hum Pathol. 2001 Jun;32(6):596-604 [11431714.001]
  • [Cites] Acta Otolaryngol. 2002 Oct;122(7):758-64 [12484654.001]
  • [Cites] Cancer. 1978 Jul;42(1):265-82 [208752.001]
  • [Cites] Cancer. 1984 Sep 15;54(6):1062-9 [6088017.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1990 Oct;99(10 Pt 1):835-8 [2221741.001]
  • [Cites] Cancer. 1991 Jan 1;67(1):172-9 [1985714.001]
  • [Cites] Am J Surg. 1992 Dec;164(6):623-8 [1334380.001]
  • [Cites] Hum Pathol. 1997 May;28(5):595-600 [9158708.001]
  • [Cites] APMIS. 1997 Jul;105(7):559-65 [9269302.001]
  • [Cites] Cancer. 1998 Apr 1;82(7):1217-24 [9529011.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1999 Feb;125(2):149-52 [10037280.001]
  • [Cites] Cancer. 1953 Nov;6(6):1065-133 [13106826.001]
  • [Cites] Br J Surg. 1958 Mar 18;45(193):477-87 [13536351.001]
  • [Cites] J Oral Maxillofac Surg. 2005 Jul;63(7):917-28 [16003616.001]
  • [Cites] Laryngoscope. 2008 Feb;118(2):258-62 [18030166.001]
  • (PMID = 20596994.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 25
  • [Other-IDs] NLM/ PMC2807532
  • [Keywords] NOTNLM ; Adenoid cystic carcinoma / Carcinoma ex pleomorphic adenoma / Grading / High grade transformation / Mucoepidermoid carcinoma / Salivary carcinoma
  •  go-up   go-down


94. Jaskoll T, Abichaker G, Htet K, Bringas P Jr, Morita S, Sedghizadeh PP, Melnick M: Cytomegalovirus induces stage-dependent enamel defects and misexpression of amelogenin, enamelin and dentin sialophosphoprotein in developing mouse molars. Cells Tissues Organs; 2010;192(4):221-39
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of the present study was to examine the effects of CMV infection on progressive tooth differentiation and amelogenesis.
  • This viral-induced pathology is coincident with stage-dependent changes in Amelx, Enam and Dspp gene expression, distribution of amelogenin, enamelin and DSP proteins, cell proliferation localization and dedifferentiation of secretory ameloblasts.
  • [MeSH-minor] Ameloblasts / cytology. Amelogenesis Imperfecta / embryology. Amelogenesis Imperfecta / virology. Animals. Cell Dedifferentiation. Cell Differentiation. Cell Proliferation. Dental Enamel Hypoplasia / embryology. Dental Enamel Hypoplasia / virology. Dental Enamel Proteins / biosynthesis. Dental Enamel Proteins / genetics. Extracellular Matrix Proteins / biosynthesis. Extracellular Matrix Proteins / genetics. Gene Expression. Gene Expression Profiling. Mice. Odontoblasts / cytology. Phosphoproteins / biosynthesis. Phosphoproteins / genetics. Sialoglycoproteins / biosynthesis. Sialoglycoproteins / genetics. Tissue Culture Techniques

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 S. Karger AG, Basel.
  • (PMID = 20484882.001).
  • [ISSN] 1422-6421
  • [Journal-full-title] Cells, tissues, organs
  • [ISO-abbreviation] Cells Tissues Organs (Print)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Amelogenin; 0 / Amelx protein, mouse; 0 / Dental Enamel Proteins; 0 / Extracellular Matrix Proteins; 0 / Phosphoproteins; 0 / Sialoglycoproteins; 0 / dentin sialophosphoprotein; 0 / tuftelin
  •  go-up   go-down


95. Misra V, Singh P, Singh PA, Ahmad S: Cytodiagnosis of dedifferentiated liposarcoma clinically masquerading as a renal tumour. Cytopathology; 2009 Jun;20(3):195-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytodiagnosis of dedifferentiated liposarcoma clinically masquerading as a renal tumour.

  • Genetic Alliance. consumer health - Liposarcoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18627405.001).
  • [ISSN] 1365-2303
  • [Journal-full-title] Cytopathology : official journal of the British Society for Clinical Cytology
  • [ISO-abbreviation] Cytopathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


96. Giangaspero F, Wellek S, Masuoka J, Gessi M, Kleihues P, Ohgaki H: Stratification of medulloblastoma on the basis of histopathological grading. Acta Neuropathol; 2006 Jul;112(1):5-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Relapse free survival for medulloblastomas with severe anaplasia [5-year rate: S(60)=49.5%], was significantly shorter than for tumours with moderate or mild anaplasia S(60)=65.4%; P=0.001).
  • These findings indicate that degree of anaplasia is the most significant histologic feature predictive of the survival of medulloblastoma patients.
  • [MeSH-minor] Adolescent. Anaplasia / pathology. Apoptosis / physiology. Biomarkers, Tumor / genetics. Child. Child, Preschool. Clinical Trials as Topic. Female. Humans. Male. Mutation. Necrosis / pathology. Polymerase Chain Reaction. Polymorphism, Single-Stranded Conformational. Survival Rate. beta Catenin / genetics

  • Genetic Alliance. consumer health - Medulloblastoma.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16685513.001).
  • [ISSN] 0001-6322
  • [Journal-full-title] Acta neuropathologica
  • [ISO-abbreviation] Acta Neuropathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / beta Catenin
  •  go-up   go-down


97. Serpell JW, Chen RY: Review of large deep lipomatous tumours. ANZ J Surg; 2007 Jul;77(7):524-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There are controversies regarding the histopathological diagnosis, nomenclature, diagnostic method, surgical management, roles of radiotherapy and the risk of metastasis, local recurrence and dedifferentiation.
  • RESULTS: Eleven deep lipomas, six deep atypical lipomas, four well-differentiated (lipoma-like) liposarcomas, three well-differentiated liposarcomas and four liposarcomas were studied.
  • Dedifferentiation occurred in one deep atypical lipoma, which transformed into a liposarcoma.
  • Key aspects in achieving a complete, but marginal resection of the deep atypical lipoma and the well-differentiated lipoma-like liposarcoma is accurate preoperative diagnosis with core biopsy and accurate imaging to assess deep unsuspected extensions of the tumour.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cell Differentiation. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / prevention & control. Retrospective Studies. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] ANZ J Surg. 2007 Dec;77(12):1129 [17973678.001]
  • (PMID = 17610686.001).
  • [ISSN] 1445-1433
  • [Journal-full-title] ANZ journal of surgery
  • [ISO-abbreviation] ANZ J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


98. Prasad CK, Muraleedharan CV, Krishnan LK: Bio-mimetic composite matrix that promotes endothelial cell growth for modification of biomaterial surface. J Biomed Mater Res A; 2007 Mar 1;80(3):644-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, assessment of the same matrix to prevent EC from dedifferentiation during in vitro culture and to promote endothelialization of biomaterials used for fabrication of cardiovascular implants is carried out.
  • Up/down regulation of m-RNA expression for a prothrombotic molecule-plasminogen activator inhibitor (PAI), and two antithrombotic molecules- nitric oxide synthetase (eNOS) and tissue plasminogen activator (t-PA) are chosen as the indicators of cell dedifferentiation during cell culture and passaging.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17051537.001).
  • [ISSN] 1549-3296
  • [Journal-full-title] Journal of biomedical materials research. Part A
  • [ISO-abbreviation] J Biomed Mater Res A
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biocompatible Materials; 0 / Plasminogen Activator Inhibitor 1; EC 1.14.13.39 / Nitric Oxide Synthase Type III; EC 3.4.21.68 / Tissue Plasminogen Activator
  •  go-up   go-down


99. Jiang Q, Huang R, Cai S, Wang CL: Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability. J Biomed Sci; 2010 Feb 03;17:6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: These results suggest that both the expression level and the level of MAPK- and/or PAK-mediated phosphorylation of CaD play key roles in regulating the cell motility by modulating the actin cytoskeleton stability in dedifferentiated vascular SMCs such as A7r5.

  • PhosphoSitePlus. gene/protein/disease-specific - PhosphoSitePlus® - comprehensive post-translational modification resource .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Sci. 2006 May 1;119(Pt 9):1691-702 [16595550.001]
  • [Cites] Am J Physiol Cell Physiol. 2002 Mar;282(3):C595-605 [11832345.001]
  • [Cites] Cell Motil Cytoskeleton. 2006 Sep;63(9):543-62 [16800003.001]
  • [Cites] Am J Physiol Cell Physiol. 2002 Mar;282(3):C606-16 [11832346.001]
  • [Cites] Cell Biochem Biophys. 2001;35(3):275-88 [11894847.001]
  • [Cites] Am J Physiol Cell Physiol. 2002 Oct;283(4):C1254-66 [12225988.001]
  • [Cites] Cell Mol Life Sci. 2003 Jan;60(1):198-211 [12613668.001]
  • [Cites] Biochemistry. 2003 Mar 11;42(9):2513-23 [12614145.001]
  • [Cites] Proteomics. 2003 May;3(5):647-57 [12748944.001]
  • [Cites] FASEB J. 2003 Jul;17(10):1316-8 [12759338.001]
  • [Cites] Angiogenesis. 2003;6(1):55-64 [14517405.001]
  • [Cites] J Cell Sci. 2004 Jul 15;117(Pt 16):3593-604 [15226374.001]
  • [Cites] Proc Natl Acad Sci U S A. 1988 Dec;85(24):9542-6 [3143999.001]
  • [Cites] J Biol Chem. 1989 May 5;264(13):7698-703 [2708386.001]
  • [Cites] Nature. 1990 Apr 12;344(6267):675-8 [2157986.001]
  • [Cites] Nature. 1991 Jan 10;349(6305):169-72 [1986309.001]
  • [Cites] Cell Motil Cytoskeleton. 1991;20(2):109-20 [1751965.001]
  • [Cites] Gene. 1992 Mar 15;112(2):197-204 [1555769.001]
  • [Cites] FEBS Lett. 1992 May 18;302(3):223-6 [1601129.001]
  • [Cites] J Biol Chem. 1992 Jul 25;267(21):14555-8 [1386078.001]
  • [Cites] Cell Motil Cytoskeleton. 1995;32(3):233-43 [8581978.001]
  • [Cites] Cell Motil Cytoskeleton. 1996;34(3):215-29 [8816288.001]
  • [Cites] Circ Res. 1998 Sep 21;83(6):661-7 [9742062.001]
  • [Cites] Biophys J. 1999 Apr;76(4):2307-16 [10096925.001]
  • [Cites] Mol Biol Cell. 1999 Oct;10(10):3097-112 [10512853.001]
  • [Cites] J Biol Chem. 2004 Dec 17;279(51):53387-94 [15456752.001]
  • [Cites] J Cell Physiol. 2005 Jun;203(3):520-8 [15521070.001]
  • [Cites] Exp Eye Res. 2006 Jun;82(6):945-58 [16679125.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2231-7 [16888241.001]
  • [Cites] Exp Cell Res. 2007 Mar 10;313(5):849-66 [17239373.001]
  • [Cites] J Biol Chem. 2007 Mar 16;282(11):8454-63 [17224451.001]
  • [Cites] FEBS Lett. 2007 Aug 7;581(20):3777-82 [17631293.001]
  • [Cites] Adv Exp Med Biol. 2008;644:250-72 [19209827.001]
  • [Cites] Int Rev Cell Mol Biol. 2009;274:1-68 [19349035.001]
  • [Cites] J Biol Chem. 2000 Jan 21;275(3):1959-65 [10636898.001]
  • [Cites] J Biol Chem. 2000 Feb 4;275(5):3213-20 [10652307.001]
  • [Cites] Mol Biol Cell. 2001 Jan;12(1):239-50 [11160835.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1422-6 [11179093.001]
  • [Cites] Am J Physiol Cell Physiol. 2001 Jun;280(6):C1680-8 [11350764.001]
  • [Cites] Exp Cell Res. 2006 Jan 15;312(2):95-110 [16289153.001]
  • (PMID = 20128924.001).
  • [ISSN] 1423-0127
  • [Journal-full-title] Journal of biomedical science
  • [ISO-abbreviation] J. Biomed. Sci.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL092252; United States / NHLBI NIH HHS / HL / R01 HL92252
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Calmodulin-Binding Proteins; 0 / enhanced green fluorescent protein; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC2846900
  •  go-up   go-down


100. Schumann D, Kujat R, Nerlich M, Angele P: Mechanobiological conditioning of stem cells for cartilage tissue engineering. Biomed Mater Eng; 2006;16(4 Suppl):S37-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Articular cartilage possesses little capacity for endogenous repair after having been damaged by disease or trauma.
  • Numerous publications show the beneficial influence of mechanobiological conditioning (e.g. mechanical compression, hydrostatic pressure, osmotic, shear, ultrasound) on the chondrogenic differentiation of dedifferentiated chondrocytes.
  • Similar results, with an increase in chondrogenic differentiation of mesenchymal progenitor cells could be detected, when the cells were loaded in three-dimensional matrices and subjected to cyclic, compressive load or low-intensity pulsed ultrasound.

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16823112.001).
  • [ISSN] 0959-2989
  • [Journal-full-title] Bio-medical materials and engineering
  • [ISO-abbreviation] Biomed Mater Eng
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 172
  •  go-up   go-down






Advertisement